Acute laryngitis and tracheitis

J10_LARYNGITIS

tracheitis: An inflammatory process affecting the wall of the trachea.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J04, J05.0 Hospital discharge: ICD-9 — 464 Hospital discharge: ICD-8 — 464\|50803 Hospital discharge: excluded ICD-9 — 4643 Hospital discharge: excluded ICD-8 — 46404 Cause of death: ICD-10 — J04, J05.0 Cause of death: ICD-9 — 464 Cause of death: ICD-8 — 464\|50803 Cause of death: excluded ICD-9 — 4643 Cause of death: excluded ICD-8 — 46404 2 out of 7 registries used, show all original rules.	6252
4. Check minimum number of events None	6252
5. Include endpoints None	6252
6. Filter based on genotype QC (FinnGen only)	6252

Control definitions (FinnGen only)

Control exclude: J10_UPPERINFEC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	J10_LARYNGITIS
CONTROL_EXCLUDE	J10_UPPERINFEC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J04\|J050
HD_ICD_9	464
HD_ICD_8	464\|50803
HD_ICD_10_EXCL
HD_ICD_9_EXCL	4643
HD_ICD_8_EXCL	46404
COD_MAINONLY
COD_ICD_10	J04\|J050
COD_ICD_9	464
COD_ICD_8	464\|50803
COD_ICD_10_EXCL
COD_ICD_9_EXCL	4643
COD_ICD_8_EXCL	46404
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute laryngitis and tracheitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	128212	46953	81099
Only index persons	93013	34477	58536
Unadjusted period prevalence (%)
Whole population	1.93	1.34	2.27
Only index persons	1.88	1.27	2.23
Median age at first event (years)
Whole population	2.45	2.67	2.25
Only index persons	2.67	3.09	2.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6252	3462	2790
Unadjusted period prevalence (%)	1.20	1.18	1.23
Median age at first event (years)	4.91	5.94	3.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5388: Matched controls
53461

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J04.0

ICD-10 Finland

Acute laryngitis

108.2

323.0

2561

445

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

+∞

323.0

1149

4640A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngitis

+∞

323.0

1116

J05.0

ICD-10 Finland

Acute obstructive laryngitis [croup]

1222.7

242.7

236

46409

ICD-8 Finland

Acute laryngitis and tracheitis, Unspecified

+∞

202.8

194

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

+∞

189.1

181

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

137.5

2848

18855

R03AC02

ATC

salbutamol; inhalant

2.0

126.6

2773

18524

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

+∞

126.2

121

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

5.2

122.4

408

834

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

121.7

1037

4473

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

112.7

896

3698

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

106.7

1135

5465

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

+∞

106.3

102

J04.2

ICD-10 Finland

Acute laryngotracheitis

26.8

103.6

145

R03BA05

ATC

fluticasone; inhalant

2.4

102.3

1066

5067

H02AB06

ATC

prednisolone; systemic

1.9

97.3

1956

12241

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

86.0

802

3572

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

82.9

614

2397

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

5.3

79.2

256

502

J01FA10

ATC

azithromycin; systemic

1.7

76.1

3336

26032

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.1

73.7

304

765

J37.0

ICD-10 Finland

Chronic laryngitis

5.9

73.2

213

368

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

+∞

72.8

J45.1

ICD-10 Finland

Nonallergic asthma

3.3

72.7

391

1227

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

72.5

1796

11761

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

71.8

606

2540

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.6

70.7

339

972

4630A

ICD-9 Finland

Acute tonsillitis[TONSILLITIS ACUTA]

+∞

69.7

R03DC03

ATC

montelukast; oral

2.2

68.6

811

4012

J01AA02

ATC

doxycycline; systemic

1.7

67.7

3142

24493

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

66.6

1457

9110

J05.1

ICD-10 Finland

Acute epiglottitis

650.9

65.9

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

3.2

65.3

375

1230

R03BA02

ATC

budesonide; inhalant

2.1

65.1

878

4588

4642A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngotracheitis

+∞

64.5

J46

ICD-10 Finland

Status asthmaticus

6.6

62.4

166

255

J01FA06

ATC

roxithromycin; oral

1.7

61.2

1615

10650

R06.0

ICD-10 Finland

Dyspnoea

2.0

60.6

885

4763

TDM10

NOMESCO Finland

Puncture of maxillary antrum

5.3

60.5

194

377

J04.1

ICD-10 Finland

Acute tracheitis

30.2

60.1

R49.01

ICD-10 Finland

Functional dysphonia

5.3

59.4

188

360

R06AE07

ATC

cetirizine; oral

1.6

58.2

2299

16887

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

58.1

748

3819

4644A

ICD-9 Finland

Acute laryngitis and tracheitis, Croup

+∞

56.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

54.2

2664

20535

J01FA09

ATC

clarithromycin; systemic

1.7

53.3

1487

9883

J01DA01

ATC

[U] cefalexin; systemic

1.5

51.4

2871

22690

R03AC03

ATC

terbutaline; inhalant

2.0

49.4

668

3463

R01AD09

ATC

mometasone; nasal

1.6

49.2

2146

15935

A02BC05

ATC

esomeprazole; systemic

1.6

46.3

1423

9637

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

46.1

828

4766

R05

ICD-10 Finland

Cough

1.9

45.9

785

4443

R49.08

ICD-10 Finland

Other specified dysphonia

6.0

45.7

130

219

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

4.0

45.7

192

491

J01FF01

ATC

clindamycin; systemic

1.7

45.4

1073

6744

R50.9

ICD-10 Finland

Fever, unspecified

2.0

45.2

633

3324

N02AX02

ATC

tramadol; systemic, rectal

1.6

45.1

1406

9546

H02AB04

ATC

methylprednisolone; systemic

2.2

45.1

519

2508

R03CC02

ATC

salbutamol; systemic

1.9

44.5

754

4249

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.8

44.4

308

1142

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

43.8

1195

7814

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

+∞

43.7

J01DB01

ATC

cefalexin; oral

1.6

42.8

4043

35227

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

41.9

918

5621

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.1

41.7

171

428

R01AD08

ATC

fluticasone; nasal

1.6

41.2

1265

8521

J45

ICD-10 Finland

Asthma

2.2

41.1

438

2043

J03.0

ICD-10 Finland

Streptococcal tonsillitis

3.3

40.2

214

665

R03BA01

ATC

beclometasone; inhalant

2.0

39.7

540

2796

50803

ICD-8 Finland

Other diseases of upper respiratory tract, Pseudocroup

+∞

39.5

M01AE02

ATC

naproxen; oral, rectal

1.5

38.7

2784

22615

4600A

ICD-9 Finland

Acute nasopharyngitis [common cold][NASOPHARYNGITIS ACUTA]

+∞

38.5

C01CA24

ATC

epinephrine; parenteral

2.3

38.3

394

1806

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

38.2

880

5456

A02BC02

ATC

pantoprazole; systemic

1.5

37.8

2327

18282

R51.80

ICD-10 Finland

Headache

1.8

37.8

764

4550

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

37.7

536

2819

R05FB02

ATC

cough suppressants and expectorants

1.6

37.6

1223

8329

H02AB07

ATC

prednisone; oral

2.0

37.6

489

2486

N02BE01

ATC

paracetamol; systemic, rectal

1.5

36.9

3767

32672

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

36.8

1633

11951

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

36.1

141

338

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.3

35.4

187

578

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

34.0

206

700

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

33.2

1553

11440

M79.6

ICD-10 Finland

Pain in limb

1.5

33.1

1361

9751

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

32.7

1731

13076

A07AA02

ATC

nystatin; oral

2.9

31.9

200

696

J01CA04

ATC

amoxicillin; systemic

1.5

31.0

4368

39531

J45.8

ICD-10 Finland

Mixed asthma

3.6

30.9

145

410

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

30.4

456

2442

R49.0

ICD-10 Finland

Dysphonia

5.5

30.4

169

XQ800

NOMESCO Finland

Prick test

2.0

30.2

419

2178

46403

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngotracheitis acuta purulenta

+∞

30.1

J01MA12

ATC

levofloxacin; systemic

1.8

30.1

533

3025

N03AX16

ATC

pregabalin; oral

1.7

30.1

723

4510

J04

ICD-10 Finland

Acute laryngitis and tracheitis

8.0

30.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

29.7

1040

7154

R06AX13

ATC

loratadine; oral

1.6

29.6

780

4991

R02

ICPC

Shortness of breath/dyspnoea

1.9

29.6

445

2385

R03DA04

ATC

theophylline; systemic, rectal

3.1

29.3

167

544

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

29.3

437

2335

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

29.3

1162

8221

R03BB04

ATC

tiotropium bromide; inhalant

2.6

29.2

226

895

R06AX27

ATC

desloratadine; oral

1.5

29.2

1420

10493

R03BA08

ATC

ciclesonide; inhalant

2.2

29.1

324

1537

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.3

28.6

109

257

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

28.5

210

807

J01FA01

ATC

erythromycin; systemic

1.6

28.5

802

5220

R01AD12

ATC

fluticasone furoate; nasal

1.5

28.4

1451

10817

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

28.2

697

4380

R03AC12

ATC

salmeterol; inhalant

3.2

28.1

154

490

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.9

27.7

405

2149

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

27.4

554

3278

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.2

27.4

279

1269

UDC00

NOMESCO Finland

Ear microscopy

2.1

26.8

311

1501

R96

ICPC

Asthma

2.1

26.5

319

1566

R03AK08

ATC

formoterol and beclometasone; inhalant

3.1

26.5

151

493

J01MA02

ATC

ciprofloxacin; systemic

1.5

26.4

1232

8991

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.0

26.2

108

274

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

26.2

1014

7112

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.6

26.0

119

331

J38.3

ICD-10 Finland

Other diseases of vocal cords

6.7

25.8

A02BC01

ATC

omeprazole; systemic

1.6

25.7

860

5827

J01FA15

ATC

telithromycin; oral

2.0

25.7

351

1811

A02BA02

ATC

ranitidine; systemic

1.8

25.4

504

2965

J38.4

ICD-10 Finland

Oedema of larynx

10.7

25.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

25.1

946

6587

M54.5

ICD-10 Finland

Low back pain

1.4

25.1

1323

9874

Z3226

NOMESCO Finland

Physiotherapist

1.6

25.0

697

4514

46099

ICD-8 Finland

Acute nasopharyngitis (common cold)

+∞

24.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

24.8

274

1296

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

24.8

354

1859

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

24.7

1011

7166

R06.2

ICD-10 Finland

Wheezing

2.4

24.6

210

878

N05BA01

ATC

diazepam; systemic, rectal

1.8

24.4

448

2567

J02AC01

ATC

fluconazole; systemic

1.4

24.1

1542

11915

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

24.0

748

4981

R07.0

ICD-10 Finland

Pain in throat

2.0

23.8

326

1682

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

23.6

951

6708

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

23.5

153

548

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

23.5

219

958

R03BB01

ATC

ipratropium bromide; inhalant

3.9

23.4

258

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

23.2

770

5199

4451

FHL

Guitar cutting

2.0

23.2

309

1581

SPAT1263

SPAT

Sampling

1.4

23.1

1943

15697

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.7

22.8

166

M03BX02

ATC

tizanidine; oral

1.3

22.7

2484

20883

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

22.7

250

1182

R42

ICD-10 Finland

Dizziness and giddiness

1.6

22.7

617

3964

M25.5

ICD-10 Finland

Pain in joint

1.4

22.7

1095

8011

P01AB01

ATC

metronidazole; oral, rectal

1.4

22.5

1426

10968

J01MA14

ATC

moxifloxacin; systemic

2.1

22.5

253

1206

R05

ICPC

Cough

1.5

22.5

956

6814

ZXA10

NOMESCO Finland

Bilateral

1.6

22.4

584

3707

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

4.9

22.3

148

J20

ICD-10 Finland

Acute bronchitis

1.9

22.3

334

1782

AA1AD

NOMESCO Finland

CT of head and brain

1.6

22.2

626

4057

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.5

22.2

175

R06AE09

ATC

levocetirizine; oral

1.6

22.0

711

4767

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

21.9

176

712

UJF32

NOMESCO Finland

Coloscopy

1.6

21.9

694

4631

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

21.8

317

1675

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.7

21.6

158

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

21.6

997

7220

EMB10

NOMESCO Finland

Tonsillectomy

1.8

21.6

375

2109

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

21.1

1119

8322

R23

ICPC

Voice symptom/complaint

3.1

21.0

118

385

R03BC03

ATC

nedocromil; inhalant

2.1

21.0

239

1144

A02BC03

ATC

lansoprazole; oral

1.5

21.0

801

5574

49099

ICD-8 Finland

Bronchitis, unspecified

5.7

20.6

103

N03AX12

ATC

gabapentin; oral

1.7

20.5

458

2784

48609

ICD-8 Finland

Pneumonia, unspecified

4.0

20.4

205

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

20.4

219

1024

R03AC13

ATC

formoterol; inhalant

2.6

20.4

154

605

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

20.2

592

3873

J01DA06

ATC

[U] cefuroxime; systemic

1.6

20.0

550

3537

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.3

19.9

102

312

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

19.8

1001

7364

Z3231

NOMESCO Finland

Registered nurse

1.4

19.8

1054

7829

4620A

ICD-9 Finland

Acute pharyngitis[PHARYNGITIS ACUTA]

+∞

19.7

R13

ICD-10 Finland

Dysphagia

2.3

19.6

183

802

J01DA08

ATC

[U] cefaclor; oral

1.5

19.5

827

5877

C03CA01

ATC

furosemide; systemic

1.6

19.3

471

2936

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

19.2

486

3059

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.2

771

5414

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

5.3

19.0

110

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

18.8

592

3934

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

18.8

1324

10310

A01AB09

ATC

miconazole; local oral

1.9

18.7

287

1545

46499

ICD-8 Finland

+∞

18.7

4641A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute tracheitis

+∞

18.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

18.6

224

1098

Z00.0

ICD-10 Finland

General medical examination

1.5

18.6

792

5627

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.6

18.5

234

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

18.5

784

5564

1240

FHL

Bronchoscopy

6.6

18.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

18.4

1212

9331

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

18.4

915

6702

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.3

3540

31803

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

18.2

211

1021

ZXE00

NOMESCO Finland

One hour or less

1.3

18.2

1565

12561

N06AX21

ATC

duloxetine; oral

1.7

18.1

383

2291

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

17.9

300

1667

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

17.6

468

2981

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

13.6

17.6

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

17.6

603

4086

X58

ICD-10 Finland

Exposure to other specified factors

1.5

17.6

635

4356

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

17.5

271

1466

WX110

NOMESCO Finland

Local anesthesy

1.3

17.4

3460

31073

R06AX22

ATC

ebastine; oral

1.5

17.2

677

4723

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

17.0

443

2808

A03FA02

ATC

cisapride; oral, rectal

2.0

17.0

212

1056

ZX120

NOMESCO Finland

Intravenous

1.8

16.7

284

1589

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

16.7

210

1052

J01.1

ICD-10 Finland

Acute frontal sinusitis

4.6

16.7

123

46400

ICD-8 Finland

+∞

16.6

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.5

16.6

131

529

R21

ICPC

Throat symptom/complaint

1.3

16.6

1287

10144

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

16.6

281

1571

S06.0

ICD-10 Finland

Concussion

1.6

16.4

470

3053

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

16.4

1951

16343

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.6

16.3

124

489

R01AD05

ATC

budesonide; nasal

1.8

16.3

291

1653

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

16.3

389

2408

R01AD11

ATC

triamcinolone; nasal

1.8

16.2

312

1813

N05CF01

ATC

zopiclone; oral

1.4

16.1

887

6605

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

16.0

129

525

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

16.0

1420

11409

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

5.3

16.0

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

16.0

139

591

J01.4

ICD-10 Finland

Acute pansinusitis

16.6

16.0

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

15.8

552

3754

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

15.8

234

1248

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

15.7

583

4016

R11

ICD-10 Finland

Nausea and vomiting

1.7

15.7

316

1865

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

15.7

367

2260

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

15.6

282

1609

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

15.6

189

933

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.3

15.6

236

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

15.6

1336

10674

N02AA05

ATC

oxycodone; systemic

1.7

15.5

300

1745

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

15.5

594

4119

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

15.4

278

1587

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.1

15.4

266

M01AH05

ATC

etoricoxib; oral

1.3

15.3

2133

18176

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

15.3

533

3618

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

15.3

3588

32599

49300

ICD-8 Finland

Asthma, bronchiale

3.4

15.2

214

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

15.1

324

1944

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

15.1

644

4566

R4130

NOMESCO Finland

Speech therapy

3.3

15.0

233

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

14.8

304

1803

N05BA04

ATC

oxazepam; oral

1.4

14.8

861

6468

N06AB04

ATC

citalopram; systemic

1.4

14.6

705

5117

L03

ICPC

Low back symptom/complaint

1.4

14.6

940

7179

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

14.5

191

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

14.5

2422

21060

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

14.4

358

2238

C07AB07

ATC

bisoprolol; oral

1.3

14.4

1026

7957

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

14.3

427

2800

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

14.2

316

R03DC01

ATC

zafirlukast; oral

4.1

14.1

131

J05AB01

ATC

aciclovir; systemic

1.4

14.1

731

5374

N06AX11

ATC

mirtazapine; oral

1.3

14.0

1115

8791

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

4.2

14.0

123

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.6

14.0

G47.3

ICD-10 Finland

Sleep apnoea

1.5

13.9

594

4207

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

13.8

229

1272

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

13.7

424

2800

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

13.7

234

1312

R06.1

ICD-10 Finland

Stridor

8.1

13.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

13.7

1726

14476

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

13.6

391

2541

A06AD11

ATC

lactulose; oral

1.6

13.5

331

2062

SPAT1254

SPAT

Administration of medicine

1.4

13.5

625

4495

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

13.5

282

1683

R4110

NOMESCO Finland

Physiotherapy

1.4

13.5

850

6458

602

Kela drug reimbursment

Children's severe malnutrition

5.2

13.5

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

5.3

13.4

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

13.4

301

1834

R06.4

ICD-10 Finland

Hyperventilation

2.8

13.4

292

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

4.9

13.4

ZXA00

NOMESCO Finland

Right side

1.4

13.3

713

5271

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

13.3

167

839

J06.0

ICD-10 Finland

Acute laryngopharyngitis

4.0

13.2

130

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

13.2

109

453

J30.3

ICD-10 Finland

Other allergic rhinitis

2.0

13.2

171

870

Z50.1

ICD-10 Finland

Other physical therapy

2.1

13.2

146

698

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

13.2

283

1701

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

13.1

259

1519

J01DC02

ATC

cefuroxime; systemic

1.8

13.1

212

1168

G44.2

ICD-10 Finland

Tension-type headache

1.5

13.0

501

3473

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.2

13.0

113

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

13.0

713

5287

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.5

13.0

172

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.3

13.0

121

531

7803A

ICD-9 Finland

General symptoms, Convulsions

3.1

13.0

231

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

13.0

496

3435

R55

ICD-10 Finland

Syncope and collapse

1.7

12.9

283

1713

R07.3

ICD-10 Finland

Other chest pain

1.7

12.9

265

1573

R52.9

ICD-10 Finland

Pain, unspecified

1.7

12.8

285

1729

SPAT1301

SPAT

No procedures

1.3

12.8

1240

10032

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

12.8

235

1351

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

12.8

152

748

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

12.8

167

852

H01

ICPC

Ear pain/earache

1.4

12.8

543

3844

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

12.7

747

5603

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

12.7

214

1194

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

12.7

108

455

Z50.5

ICD-10 Finland

Speech therapy

2.8

12.7

279

S18

ICPC

Laceration/cut

1.3

12.7

1383

11363

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

12.6

964

7538

XF622

NOMESCO Finland

Measurement of minute volume of heart

8.9

12.6

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.9

12.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

12.6

362

2353

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

12.6

412

2760

N05CF02

ATC

zolpidem; oral

1.4

12.6

565

4044

J38.5

ICD-10 Finland

Laryngeal spasm

12.2

12.5

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

12.5

154

767

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.5

2956

26536

4650A

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Acute laryngopharyngitis

+∞

12.5

4658X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Other multiple sites

+∞

12.5

46209

ICD-8 Finland

Acute pharyngitis, Unspecified

+∞

12.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.4

2203

19159

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

12.4

963

7545

N05AH04

ATC

quetiapine; oral

1.4

12.4

752

5670

L28

ICPC

Limited function/disability (L)

1.6

12.4

349

2257

J02.0

ICD-10 Finland

Streptococcal pharyngitis

2.4

12.4

106

450

R03BC01

ATC

cromoglicic acid; inhalant

2.5

12.3

376

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

12.3

193

1051

R74

ICPC

Upper respiratory infection acute

1.3

12.3

1600

13430

N06AA09

ATC

amitriptyline; systemic

1.8

12.3

221

1261

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

12.2

143

697

A03

ICPC

Fever

1.3

12.2

899

6990

M01AX17

ATC

nimesulide; oral

1.4

12.2

533

3792

SPAT1312

SPAT

General health counselling

1.3

12.2

1564

13100

H02AB09

ATC

hydrocortisone; systemic

2.5

12.2

383

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.7

12.2

236

1376

UDQ02

NOMESCO Finland

Direct laryngoscopy

5.0

12.1

L20.0

ICD-10 Finland

Besnier prurigo

1.5

12.1

425

2890

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

12.0

362

ZXA05

NOMESCO Finland

Left side

1.4

12.0

655

4851

R01AD01

ATC

beclometasone; nasal

1.4

12.0

507

3583

Q90.9

ICD-10 Finland

Down syndrome, unspecified

26.5

12.0

Z2221

NOMESCO Finland

Medical doctor

1.3

11.9

1053

8399

M02AA07

ATC

piroxicam; topical

1.3

11.9

951

7482

SPAT1310

SPAT

Counselling related to known health issue

1.3

11.8

1370

11322

RD210

NOMESCO Finland

2.3

11.8

108

473

SPAT1153

SPAT

Removal of sutures

1.3

11.8

929

7296

B01AB05

ATC

enoxaparin; parenteral

1.4

11.8

751

5711

L50.0

ICD-10 Finland

Allergic urticaria

2.2

11.6

113

511

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

11.6

2625

23371

EMB30

NOMESCO Finland

Adenotomy

1.6

11.6

298

1883

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

11.5

264

1618

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.5

684

5141

4452

FHL

Tonsil surgery

2.0

11.5

140

697

1420

FHL

Laryngomicroscopy

8.0

11.5

UGC02

NOMESCO Finland

Rigid bronchoscopy

8.0

11.5

UJC01

NOMESCO Finland

Scopy of lower throat

4.9

11.4

E66.8

ICD-10 Finland

Other obesity

1.8

11.4

191

1066

J38.7

ICD-10 Finland

Other diseases of larynx

5.6

11.4

E0000UV

ATC

1.2

11.3

1713

14592

R03CC03

ATC

terbutaline; systemic

1.8

11.3

203

1159

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

11.2

324

2110

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

8.2

11.2

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.7

11.2

131

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

11.2

237

1423

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.6

11.0

322

2101

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

11.0

282

1782

Z71.8

ICD-10 Finland

Other specified counselling

1.3

10.9

1041

8380

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

10.9

1097

8894

K30

ICD-10 Finland

Functional dyspepsia

1.5

10.9

325

2131

UDQ22

NOMESCO Finland

Microlaryngoscopy

5.3

10.9

M48.0

ICD-10 Finland

Spinal stenosis

1.8

10.9

194

1105

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

10.8

380

2585

M01AB05

ATC

diclofenac; systemic, rectal

1.2

10.8

2451

21761

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

10.8

112

523

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

10.8

398

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

10.7

189

1073

G43.8

ICD-10 Finland

Other migraine

2.7

10.7

261

Z00.8

ICD-10 Finland

Other general examinations

1.6

10.6

296

1911

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

21.3

10.6

M79.7

ICD-10 Finland

Fibromyalgia

2.2

10.6

108

500

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

10.5

614

4597

E000001

ATC

1.3

10.5

905

7183

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

10.5

305

1987

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

10.5

258

1615

ZXD05

NOMESCO Finland

Urgent procedure

1.3

10.4

1184

9742

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

10.4

290

1870

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

10.4

148

783

4122

FHL

Tympanostomy (tympanic tube)

1.9

10.4

142

741

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.9

10.3

105

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

10.3

237

1457

WZC30

NOMESCO Finland

Teaching

1.5

10.2

351

2374

DQA10

NOMESCO Finland

Biopsy of larynx

6.3

10.2

S80.0

ICD-10 Finland

Contusion of knee

1.6

10.1

264

1678

J02

ICD-10 Finland

Acute pharyngitis

1.8

10.1

161

886

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

1.9

10.0

153

827

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

10.0

219

1326

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

10.0

460

3301

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

10.0

161

890

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

9.9

223

1361

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

4.9

9.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

9.9

307

2031

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.9

518

3806

N03AE01

ATC

clonazepam; systemic

1.8

9.9

169

954

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

9.9

615

4655

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

9.8

207

1240

ZXD20

NOMESCO Finland

Day surgery

1.4

9.8

423

3000

SPAT1283

SPAT

Restricted health certificate

1.3

9.8

1175

9723

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

25.8

9.8

SPAT1059

SPAT

Spirometry at the office

1.9

9.7

145

780

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

9.7

124

629

E000002

ATC

1.4

9.7

533

3949

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.3

9.7

394

L15

ICPC

Knee symptom/complaint

1.3

9.7

700

5417

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

9.6

292

1926

A01AB04

ATC

amphotericin B; local oral

2.1

9.6

100

467

ACC51

NOMESCO Finland

Release of median nerve

1.7

9.6

191

1128

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.0

9.6

186

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.4

9.6

332

ZX108

NOMESCO Finland

Inhalation

5.3

9.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

9.5

312

2092

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.5

1014

8262

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

9.5

696

5393

N06AB03

ATC

fluoxetine; oral

1.4

9.5

426

3043

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

9.5

271

1763

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

9.5

154

853

R60.0

ICD-10 Finland

Localized oedema

1.6

9.5

235

1476

D07AA02

ATC

hydrocortisone; topical

1.3

9.5

649

4984

J38.2

ICD-10 Finland

Nodules of vocal cords

4.1

9.4

46402

ICD-8 Finland

+∞

9.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

9.3

143

776

R10.0

ICD-10 Finland

Acute abdomen

1.9

9.3

123

635

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

9.3

309

2079

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

9.2

189

1127

N02AC04

ATC

dextropropoxyphene; oral

2.7

9.2

232

SPAT1058

SPAT

PEF monitoring instruction

1.6

9.2

243

1552

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.2

9.2

390

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

2.1

9.1

445

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

9.1

1377

11678

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

9.1

221

1379

R06AX26

ATC

fexofenadine; oral

1.6

9.1

254

1642

EBA00

NOMESCO Finland

Extraction of tooth

1.2

9.0

1536

13180

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

9.0

300

2017

DHB50

NOMESCO Finland

Turbinoplasty

2.1

9.0

475

L04AA01

ATC

[U] ciclosporin; systemic

3.2

9.0

140

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.0

9.0

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

9.0

870

7002

R06.5

ICD-10 Finland

Mouth breathing

1.5

9.0

270

1778

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

9.0

4355

41279

L04AX01

ATC

azathioprine; systemic

1.7

9.0

170

992

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

9.0

262

1712

WX882

NOMESCO Finland

High dependency care

2.2

9.0

400

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

9.9

9.0

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

8.9

338

B01AA03

ATC

warfarin; systemic

1.5

8.9

300

2024

UDM02

NOMESCO Finland

Sinoscopy

2.6

8.9

249

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

8.8

256

1668

A02BC04

ATC

rabeprazole; oral

1.6

8.8

242

1556

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

6.0

8.8

SPAT1216

SPAT

Assessment of functional ability

1.5

8.8

328

2261

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

8.8

411

2960

N06AX16

ATC

venlafaxine; oral

1.3

8.8

544

4112

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.1

8.7

149

R09

ICPC

Sinus symptom/complaint

1.5

8.7

308

2101

0092A

ICD-9 Finland

Ill-defined intestinal infections, Infectious diarrhoea

2.7

8.7

222

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

8.7

138

762

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

8.7

162

942

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

8.6

226

1437

7580A

ICD-9 Finland

Chromosomal anomalies, Down's syndrome

49.7

8.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

8.6

395

2835

M54.3

ICD-10 Finland

Sciatica

1.8

8.6

154

880

N03AX09

ATC

lamotrigine; oral

1.6

8.6

218

1376

N06AB10

ATC

escitalopram; oral

1.3

8.6

908

7383

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

8.6

681

5337

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

8.6

123

654

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.5

242

1570

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

8.5

300

2043

A46

ICD-10 Finland

Erysipelas

1.5

8.5

304

2076

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

8.5

237

1531

R05DB20

ATC

other cough suppressants - combinations

1.6

8.5

215

1357

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

8.5

196

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.7

8.5

179

1076

A04

ICPC

Weakness/tiredness general

1.3

8.4

534

4048

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

27.3

8.4

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

8.4

587

4514

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

8.4

106

539

J06.80

ICD-10 Finland

Continuously repeating infections of a child

19.9

8.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

8.4

101

503

Z2446

NOMESCO Finland

Social worker

1.5

8.4

288

1950

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.8

8.4

176

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

8.4

185

1129

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

8.4

108

555

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

8.4

248

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

8.4

112

584

N30.0

ICD-10 Finland

Acute cystitis

1.4

8.3

431

3158

N03AG01

ATC

valproic acid; systemic, rectal

1.6

8.3

232

1498

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

8.3

202

1260

R00.2

ICD-10 Finland

Palpitations

1.5

8.3

241

1572

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

8.3

1368

11691

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

8.3

149

857

R29

ICPC

Respiratory symptom/complaint other

1.6

8.2

222

1426

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

8.2

319

2216

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

3.9

8.2

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.5

8.2

102

R51.81

ICD-10 Finland

Facial pain NOS

2.3

8.2

300

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

8.2

562

4311

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

8.2

176

1063

1430

FHL

Laryngoscopy (direct)

14.4

8.2

J38.6

ICD-10 Finland

Stenosis of larynx

14.4

8.2

M79.1

ICD-10 Finland

Myalgia

1.4

8.1

450

3339

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

8.1

200

1257

J36

ICD-10 Finland

Peritonsillar abscess

1.8

8.1

142

808

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

8.1

406

2964

GBB00

NOMESCO Finland

Tracheostomy

4.0

8.1

ZXC10

NOMESCO Finland

Use of laser

2.4

8.1

259

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

8.1

335

2363

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

8.1

357

2548

R4190

NOMESCO Finland

Nutritional therapy

1.8

8.0

142

813

R49.09

ICD-10 Finland

Unspecified dysphonia

3.6

8.0

A92

ICPC

Allergy/allergic reaction NOS

1.7

8.0

152

886

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

8.0

282

1924

WX892

NOMESCO Finland

Monitored bed care

1.6

8.0

197

1237

48509

ICD-8 Finland

Bronchopneumonia, unspecified

2.9

8.0

157

RK260

NOMESCO Finland

9.9

8.0

R04.2

ICD-10 Finland

Haemoptysis

2.4

8.0

272

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

8.0

368

2649

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

5.0

7.9

N03AF02

ATC

oxcarbazepine; oral

1.8

7.9

120

653

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.6

7.9

210

1342

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.2

7.9

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

7.9

352

2516

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

7.9

296

2044

D01

ICPC

Abdominal pain/cramps general

1.3

7.9

502

3811

R51

ICD-10 Finland

Headache

1.6

7.9

213

1371

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

7.8

268

1818

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.8

613

4795

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

7.8

306

2133

N05CD07

ATC

temazepam; oral

1.6

7.7

213

1374

J39.1

ICD-10 Finland

Other abscess of pharynx

9.3

7.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

7.7

116

628

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

7.7

513

3917

FDA00

NOMESCO Finland

Aortoplasty and aorto-pulmonary shunt for HLHS

44.7

7.7

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

7.7

203

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

7.7

460

3460

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.2

7.6

114

N05BB01

ATC

hydroxyzine; systemic

1.5

7.6

238

1583

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

7.6

221

1442

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.1

7.6

406

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.0

7.6

J01

ICD-10 Finland

Acute sinusitis

1.6

7.6

173

1065

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.5

758

6124

L02

ICPC

Back symptom/complaint

1.4

7.5

359

2600

SPAT1260

SPAT

Consultation of another employee

1.3

7.5

592

4633

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

7.5

215

1401

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

7.5

236

1572

C08DA01

ATC

verapamil; systemic

2.0

7.5

415

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

9.9

7.5

4224

FHL

Endonasal anthrostomy

3.7

7.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

7.4

384

K59.0

ICD-10 Finland

Constipation

1.7

7.4

150

897

J47

ICD-10 Finland

Bronchiectasis

3.5

7.4

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

4.4

7.4

R77

ICPC

Laryngitis/tracheitis acute

4.4

7.4

L12

ICPC

Hand/finger symptom/complaint

1.3

7.4

577

4511

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.2

7.4

339

FM2CE

NOMESCO Finland

2.7

7.3

172

N05BA12

ATC

alprazolam; oral

1.5

7.3

275

1902

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

7.3

146

868

R06AX11

ATC

astemizole; oral

1.7

7.3

146

868

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

7.3

995

8319

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

7.3

373

2731

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

7.3

200

1293

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

7.2

118

661

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

7.2

155

942

F82

ICD-10 Finland

Specific developmental disorder of motor function

2.8

7.2

159

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.2

290

2033

Q32.0

ICD-10 Finland

Congenital tracheomalacia

15.6

7.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.2

1449

12593

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

7.2

461

3503

P85

ICPC

Mental retardation

5.7

7.1

A07AA09

ATC

vancomycin; oral

3.3

7.1

104

50609

ICD-8 Finland

Chronic laryngitis, Unspecified

29.8

7.1

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

7.1

390

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.6

7.1

157

960

SPAT1211

SPAT

Application of soft bandage

1.4

7.1

334

2411

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.6

7.1

170

1063

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.5

7.1

203

J02AC02

ATC

itraconazole; systemic

1.3

7.1

496

3818

R75

ICPC

Sinusitis acute/chronic

1.7

7.1

153

929

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

7.0

127

731

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

7.0

248

1694

XG460

NOMESCO Finland

Short time oxymetry

3.1

7.0

111

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

7.0

129

751

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

7.0

285

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

7.0

253

1739

EMB20

NOMESCO Finland

Adenotonsillectomy

1.8

7.0

114

640

127

Kela drug reimbursment

Transplant complication

2.7

7.0

167

M54.8

ICD-10 Finland

Other dorsalgia

1.7

7.0

128

742

J32.4

ICD-10 Finland

Chronic pansinusitis

3.0

6.9

123

0088X

ICD-9 Finland

Intestinal infections due to other organisms, Other organism, not elsewhere classified

2.3

6.9

255

R35

ICD-10 Finland

Polyuria

1.7

6.9

137

813

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

6.9

232

1570

H92.0

ICD-10 Finland

Otalgia

1.5

6.9

205

1349

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

6.9

155

955

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

6.9

406

3049

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

6.8

486

3746

A08.0

ICD-10 Finland

Rotaviral enteritis

2.8

6.8

140

XF402

NOMESCO Finland

ECG with work load test

1.5

6.8

206

1359

ZX112

NOMESCO Finland

Subcutaneous

2.4

6.8

231

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.8

271

A04AA01

ATC

ondansetron; systemic, rectal

1.6

6.8

159

989

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

6.8

213

1420

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

1.8

6.8

114

644

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

6.8

842

6970

G43.3

ICD-10 Finland

Complicated migraine

2.1

6.7

318

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

9.2

6.7

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

39.7

6.7

75930

ICD-8 Finland

Congenital syndromes affecting multiple systems, Down's disease

39.7

6.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

6.7

117

669

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

6.7

1390

12096

S01AA03

ATC

neomycin; ophthalmic (antibiotics)

3.0

6.7

115

I50.0

ICD-10 Finland

Congestive heart failure

2.0

6.7

416

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.7

261

1818

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.9

6.7

N89

ICPC

Migraine

1.5

6.7

186

1206

-1

NOMESCO Finland

1.2

6.7

1804

16055

M01AB55

ATC

diclofenac, combinations; oral

1.7

6.7

120

691

ZXC60

NOMESCO Finland

Application of heat

2.4

6.7

228

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

6.7

262

1830

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

6.7

239

1639

N06BA04

ATC

methylphenidate; oral

1.6

6.6

160

1003

R49

ICD-10 Finland

Voice disturbances

6.4

6.6

R52.2

ICD-10 Finland

Other chronic pain

1.9

6.6

511

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.4

6.6

204

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

6.6

177

1140

T82

ICPC

Obesity

1.7

6.5

126

742

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

6.5

143

873

J05AB11

ATC

valaciclovir; oral

1.4

6.5

372

2774

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

6.5

213

M01AH02

ATC

rofecoxib; oral

1.5

6.5

239

1650

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.5

159

999

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.5

368

2744

120

Kela drug reimbursment

Hypogammaglobulinaemia

9.9

6.5

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

6.5

181

1178

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.4

6.5

279

1983

N03AF01

ATC

carbamazepine; oral, rectal

1.7

6.5

118

683

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

6.4

120

701

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

6.4

563

4469

C01AA05

ATC

digoxin; systemic

1.9

6.4

479

N05AA02

ATC

levomepromazine; systemic

1.7

6.4

122

718

4661A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchiolitis

4.1

6.4

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.1

6.4

Y0499

ICD-8 Finland

Investigation of respiratory system

4.1

6.4

ZX114

NOMESCO Finland

Intramuscular

2.4

6.4

219

N04BC05

ATC

pramipexole; oral

1.6

6.4

140

854

B01AC04

ATC

clopidogrel; oral

1.5

6.4

201

1341

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

6.4

223

1521

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

6.4

163

1038

7151

FHL

Kidney transplantation

69.4

6.4

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.4

6.4

243

1687

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

6.4

148

916

XG405

NOMESCO Finland

Education on PEF monitoring

2.6

6.4

159

M77.4

ICD-10 Finland

Metatarsalgia

1.6

6.4

164

1045

C07AA05

ATC

propranolol; systemic

1.2

6.4

698

5693

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.4

2629

24147

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.4

148

921

Q25.0

ICD-10 Finland

Patent ductus arteriosus

4.6

6.3

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.3

3485

32699

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

6.3

177

1150

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

6.3

243

1693

A01

ICPC

Pain general/multiple sites

1.5

6.3

216

1472

C05AA01

ATC

hydrocortisone; rectal, topical

1.8

6.3

102

570

E000003

ATC

1.6

6.3

166

1065

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

4.4

6.3

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

6.3

215

J35.8

ICD-10 Finland

Other chronic diseases of tonsils and adenoids

2.2

6.3

276

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

6.3

409

3117

R4120

NOMESCO Finland

Occupational therapy

1.5

6.2

181

1185

4643A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute epiglottitis

+∞

6.2

FBA96

NOMESCO Finland

Other suture or repair of pulmonary artery

+∞

6.2

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

6.2

316

2314

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

6.2

456

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

6.2

290

1220

FHL

Arthroscopy

1.9

6.2

471

Q21.21

ICD-10 Finland

Atrioventricular duct

26.5

6.2

FAE00

NOMESCO Finland

Anastomosis to pulmonary artery from superior vena cava

26.5

6.2

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

6.2

188

1244

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

6.2

126

755

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

6.2

200

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

6.1

383

2902

N06AA10

ATC

nortriptyline; systemic

2.2

6.1

251

R05DA01

ATC

ethylmorphine; oral

1.5

6.1

211

1437

WX722

NOMESCO Finland

PEEP

1.9

6.1

465

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.5

6.1

SPAT1360

SPAT

Extensive global examination

1.5

6.1

196

1316

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

6.1

212

1446

R01AC01

ATC

cromoglicic acid; nasal

1.5

6.1

181

1195

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

6.1

369

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

6.1

260

1848

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.1

6.1

101

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

6.1

522

4131

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

6.1

334

D07AD01

ATC

clobetasol; topical

1.3

6.1

407

3116

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

6.0

514

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

6.0

362

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.9

6.0

403

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

896

4559

2.09

81.08

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

627

2973

2.20

67.36

1.8

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

629

3058

2.14

63.26

1.9

1.6

—

(3023368) Bacteria identified in Blood by Culture

1235

7737

1.71

56.61

4.4

3.9

—

(3013115) Eosinophils [#/volume] in Blood

2937

22900

1.50

51.41

7.4

6.1

e9/l

0.2

1.40

2620

20274

(3019198) Lymphocytes [#/volume] in Blood

2957

23119

1.50

50.87

6.9

5.7

e9/l

2.0

0.06

2663

20546

(3006315) Basophils [#/volume] in Blood

2845

22102

1.50

50.28

7.0

5.7

e9/l

0.0

0.02

2498

19223

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1992

14365

1.54

50.22

1.9

1.6

—

(3001604) Monocytes [#/volume] in Blood

2836

22041

1.49

49.88

6.9

5.7

e9/l

0.6

0.5

3.86

2501

19192

(3013826) Glucose [Moles/volume] in Serum or Plasma

2833

22043

1.49

49.36

5.7

4.2

mmol/l

6.5

6.4

0.57

2609

19833

(3013650) Neutrophils [#/volume] in Blood by Automated count

3162

25220

1.48

48.22

9.4

8.3

e9/l

4.1

3.9

2.74

2806

21981

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1613

11267

1.55

46.21

2.6

2.4

u/l

53.3

56.9

2.44

1495

10421

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2222

16619

1.49

46.11

7.9

6.0

mmol/l

1.2

0.25

1904

14135

(3019069) Monocytes/100 leukocytes in Blood

2703

21026

1.47

46.01

7.1

6.0

8.3

8.2

0.40

2549

19886

(3007853) Bacteria identified in Skin by Aerobe culture

778

4523

1.79

45.51

2.0

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1605

11236

1.55

45.38

3.4

2.6

ng/l

33.8

58.7

0.59

818

5428

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2024

14910

1.50

44.96

8.3

5.6

mmol/l

1.2

0.58

1854

13649

(3002030) Lymphocytes/100 leukocytes in Blood

2812

22128

1.46

44.60

6.9

5.7

30.2

30.5

0.77

2663

20878

(42870588) Differential panel, method unspecified - Blood

1937

14205

1.50

43.70

6.9

6.0

—

(3018010) Neutrophils/100 leukocytes in Blood

2770

21790

1.46

43.69

6.7

5.6

55.4

0.03

2625

20621

(3006504) Eosinophils/100 leukocytes in Blood

2674

20900

1.46

43.60

7.0

5.8

2.9

2.8

0.49

2499

19643

(3022096) Basophils/100 leukocytes in Blood

2587

20165

1.45

42.40

7.1

5.9

0.6

0.7

2.17

2424

18969

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2389

18441

1.45

40.73

5.6

5.2

umol/l

11.1

11.5

0.59

2226

17294

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3589

29902

1.43

39.95

7.1

6.2

u/l

77.7

76.8

0.57

3417

28188

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

453

2318

2.00

39.08

7.3

3.9

kpa

5.1

0.59

430

2193

(3009343) pH of Capillary blood

448

2304

1.99

38.08

7.3

3.9

7.4

0.27

224

(3032080) INR in Blood by Coagulation assay

1633

11853

1.48

37.60

6.8

6.0

inr

1.1

0.57

552

3814

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

439

2254

1.99

37.48

7.3

3.9

mmol/l

1.3

1.2

0.09

305

1618

(3000850) Epithelial cells [#/volume] in Urine

1085

7256

1.57

36.50

2.8

2.3

e6/l

6.5

6.7

0.20

960

6295

(3013707) Erythrocyte sedimentation rate by Westergren method

3662

30928

1.41

35.70

4.3

3.4

mm/h

9.0

8.7

1.03

3441

28908

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1236

8586

1.52

34.82

2.3

1.8

mg/l

1.1

1.0

0.24

876

6070

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5243

47520

1.57

34.20

13.8

9.1

mg/l

20.0

21.1

1.73

4174

34622

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

120

345

3.47

34.16

1.7

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

136

429

3.17

33.38

1.6

1.5

—

(40758558) Short blood count panel - Blood

1436

10380

1.47

33.04

7.9

6.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

653

2.72

32.79

1.7

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

561

3257

1.76

32.45

1.6

1.2

u/ml

322.7

273.1

0.38

528

3021

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

160

576

2.78

31.08

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

160

576

2.78

31.08

1.4

1.2

—

(3021589) Normoblasts [#/volume] in Blood

2490

20005

1.38

31.06

9.7

7.8

e9/l

0.0

0.51

2082

16202

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2139

16821

1.39

30.17

2.7

2.2

nmol/l

71.8

71.7

0.06

2002

15693

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

906

6057

1.55

29.98

3.7

2.8

ng/l

895.9

1021.2

0.35

734

4845

(3005719) IgG [Mass/volume] in Serum or Plasma

539

3169

1.74

29.75

3.0

2.4

g/l

10.0

10.6

3.48

498

2906

(3002582) Erythrocytes [#/volume] in Urine

1487

11006

1.43

29.68

3.5

2.7

e6/l

68.0

88.5

0.22

1160

8142

(3030467) Casts [#/volume] in Urine by Automated count

1369

10001

1.45

29.27

3.4

2.7

e6/l

0.3

0.10

1047

7260

(36304419) Bacteria [Presence] in Urine

1376

10069

1.44

29.14

3.4

2.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

267

1257

2.14

28.77

9.3

4.4

kpa

9.4

9.3

0.31

255

1195

(3024561) Albumin [Mass/volume] in Serum or Plasma

1904

14778

1.39

28.73

5.3

4.7

g/l

36.8

37.2

2.55

1788

13757

(3018095) Leukocytes [#/volume] in Urine

1791

13770

1.39

28.57

4.0

3.1

e6/l

65.8

74.6

0.23

1272

8892

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

170

661

2.57

28.40

1.8

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

780

5105

1.58

28.23

4.9

3.7

mmol/l

0.8

0.50

735

4786

(3036481) Cortisol [Moles/volume] in Serum or Plasma

629

3911

1.65

28.11

2.3

1.9

nmol/l

364.9

381.8

1.48

580

3602

(3022313) Gas panel - Capillary blood

340

1767

1.95

27.93

7.7

4.1

—

(3035350) Ketones [Presence] in Urine by Test strip

2580

21139

1.35

27.16

3.5

2.9

estimate

0.0

0.02

525

3977

(3026782) Osmolality of Urine

986

6848

1.50

27.07

2.9

2.4

mosm/kgh2o

545.5

561.5

1.24

861

5810

(3029937) Albumin [Presence] in Urine by Test strip

1455

10879

1.41

27.03

3.8

3.1

estimate

0.0

0.04

540

3998

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

289

3.38

26.89

1.8

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2598

21352

1.34

26.61

3.5

2.9

estimate

0.0

0.07

541

4009

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

321

1664

1.95

26.56

7.7

4.2

mmol/l

24.2

24.4

0.84

311

1600

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1272

9317

1.43

26.43

2.3

2.0

u/l

209.6

258.4

0.98

1215

8826

(3031040) Bacteria [#/volume] in Urine by Automated count

3241

27561

1.33

26.06

4.5

3.5

e6/l

155.2

1486.3

3.52

325

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4079

35899

1.35

25.84

4.2

3.6

pmol/l

14.6

14.5

2.81

3772

32996

(3021601) Nitrite [Presence] in Urine by Test strip

2573

21178

1.34

25.83

4.7

4.1

estimate

0.0

0.50

554

4127

(3019550) Sodium [Moles/volume] in Serum or Plasma

4889

44309

1.42

25.71

14.0

9.7

mmol/l

139.5

139.6

1.65

4753

42861

(3023103) Potassium [Moles/volume] in Serum or Plasma

4902

44450

1.42

25.68

14.0

9.7

mmol/l

3.9

0.32

4752

42867

(3018418) pH of Serum or Plasma

1278

9438

1.42

25.22

4.0

3.6

7.4

0.01

258

1778

(3042936) Bacteria identified in Isolate by Culture

727

4806

1.55

25.00

2.1

1.9

—

(3026008) Bacteria identified in Urine by Culture

1340

10022

1.40

24.49

2.8

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

677

4439

1.56

24.10

7.4

6.1

mmol/l

1.1

0.99

639

4171

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

387

2205

1.78

23.74

1.7

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

421

2474

1.72

23.16

1.4

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3426

29645

1.31

22.96

4.3

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1261

9443

1.40

22.64

2.7

2.2

mg/l

2.7

0.28

1092

8092

(3018677) aPTT in Platelet poor plasma by Coagulation assay

737

4991

1.51

22.56

3.1

2.3

30.2

29.6

2.11

718

4834

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4772

43350

1.37

22.45

4.0

3.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1437

11013

1.37

22.36

1.6

1.4

g/l

2.0

2.1

1.77

913

6847

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1183

8789

1.40

22.20

1.6

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

780

5375

1.49

21.91

2.7

2.3

umol/l

14.0

14.5

0.76

740

5023

(40760892) CBC W Ordered Manual Differential panel - Blood

1402

10737

1.37

21.84

4.6

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

406

2404

1.71

21.72

2.0

1.7

g/l

1.2

1.3

0.48

376

2242

(3023419) Bacteria identified in Sputum by Culture

219

3.45

21.68

4.5

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

258

1333

1.94

21.57

1.2

1.1

—

(4062490)

109

392

2.77

21.33

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4650

42179

1.35

21.27

4.9

4.2

mu/l

2.2

2.0

0.21

4398

39709

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

910

6502

1.44

21.16

1.3

1.2

u/ml

9.8

9.4

0.07

357

2711

(3037522) Nuclear Ab [Titer] in Serum

852

6029

1.45

20.84

1.4

titre

582.2

529.0

0.32

157

1064

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

306

2.99

20.76

2.9

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

979

7129

1.42

20.45

3.0

2.7

ug/g

113.0

124.5

0.54

785

5673

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

283

1536

1.85

20.37

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

163

726

2.24

20.24

1.2

1.3

—

(44790048)

103

370

2.77

20.22

1.8

1.4

—

(44806118)

103

370

2.77

20.22

1.8

1.4

—

(44790049)

103

370

2.77

20.22

1.8

1.4

—

(44790047)

103

370

2.77

20.22

1.8

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

444

2750

1.63

19.98

6.7

4.1

kpa

4.8

4.9

0.27

428

2653

(3028192) IgG subclass 2 [Mass/volume] in Serum

106

392

2.69

19.69

1.3

g/l

3.0

0.02

258

(3024139) IgG subclass 3 [Mass/volume] in Serum

106

392

2.69

19.69

1.3

g/l

0.4

0.00

257

(3027135) IgG subclass 1 [Mass/volume] in Serum

106

393

2.68

19.59

1.3

g/l

6.0

6.9

2.25

258

(3021447) Carbon dioxide [Partial pressure] in Venous blood

502

3248

1.57

18.80

6.7

4.4

kpa

5.8

5.9

0.85

483

3142

(3002032) Base excess in Venous blood by calculation

499

3225

1.57

18.78

6.9

4.4

mmol/l

1.5

1.6

0.41

408

2561

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

1.9

1.0

1.24

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

2.6

4.5

0.65

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

1.3

2.4

0.50

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

0.7

1.9

0.64

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

2.5

3.8

0.39

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

0.4

1.0

0.87

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

2.3

0.7

0.46

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

0.9

1.1

0.13

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.78

18.76

1.6

1.5

mg/l

1.0

2.0

0.39

(3004789) Transferrin [Mass/volume] in Serum or Plasma

704

4897

1.47

18.71

2.7

2.3

g/l

2.5

2.71

666

4566

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.41

18.70

1.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2634

22387

1.28

18.63

3.3

2.7

ug/l

85.0

85.1

0.00

2480

21205

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

151

675

2.23

18.61

2.7

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2012

16536

1.29

18.56

3.5

2.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1773

14353

1.30

18.29

3.4

3.1

u/l

31.0

31.6

0.20

1687

13660

(3000991) Gas panel - Venous blood

465

2980

1.58

18.15

13.2

8.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

234

1242

1.89

18.08

1.9

1.8

g/l

1.2

1.09

221

1195

(3015235) Bicarbonate [Moles/volume] in Capillary blood

154

703

2.19

18.04

6.8

3.1

mmol/l

24.2

0.06

142

627

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

229

1208

1.90

18.03

1.9

1.8

g/l

0.2

0.55

217

1157

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1627

13046

1.31

17.95

1.9

1.7

pmol/l

96.9

98.1

0.46

871

7035

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.34

17.86

1.6

mg/l

1.3

2.2

0.42

(3015377) Calcium [Moles/volume] in Serum or Plasma

1444

11404

1.32

17.74

2.7

2.9

mmol/l

2.3

2.4

1.85

1290

10258

(3014111) Lactate [Moles/volume] in Serum or Plasma

431

2745

1.59

17.26

10.7

7.8

mmol/l

1.4

0.01

409

2631

(3022217) INR in Platelet poor plasma by Coagulation assay

447

2874

1.57

17.19

16.3

15.9

inr

1.2

1.1

0.80

455

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

821

5964

1.41

17.17

3.0

2.4

e6/l

1.2

1.1

0.28

479

3128

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

123

3.94

17.14

1.1

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

433

2774

1.58

16.91

9.7

8.0

mmol/l

7.4

7.5

0.17

420

2665

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1601

12897

1.30

16.87

1.4

u/ml

1.6

1.8

0.28

402

3452

(4010399)

377

2340

1.62

16.81

1.4

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

641

4477

1.46

16.60

2.9

2.4

23.2

24.3

1.12

574

3907

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

933

6967

1.37

16.50

1.3

1.2

iu/ml

18.1

25.9

2.73

282

2005

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

790

5738

1.41

16.49

3.2

2.5

e6/l

3.1

3.0

0.11

449

2912

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

236

1296

1.82

16.40

9.6

5.8

mg/l

1.3

1.2

0.29

228

1231

(1175426) CD3 cells/100 lymphocytes in Blood

343

2.64

16.35

2.8

2.2

69.2

72.4

0.80

332

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

338

2.64

16.29

2.8

2.2

11.0

13.1

1.03

207

(3052851) Hemolysis interference index of Serum or Plasma

192

997

1.92

15.89

3.0

2.6

—

(40761535) Cells panel - Urine sediment

386

2462

1.58

15.36

3.3

3.0

—

(40761511) CBC panel - Blood by Automated count

5395

50687

1.38

15.16

11.7

8.5

—

(3016502) Oxygen saturation in Arterial blood

407

2642

1.55

15.00

11.0

8.5

96.1

0.08

392

2542

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

344

2149

1.61

14.94

8.2

4.8

mmol/l

23.8

24.0

0.49

322

2001

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

455

3029

1.52

14.93

10.4

7.9

kpa

5.1

0.33

434

2885

(3014576) Chloride [Moles/volume] in Serum or Plasma

525

3601

1.48

14.89

9.9

7.4

mmol/l

104.7

0.02

514

3533

(3013512) EKG study

1064

8224

1.33

14.88

3.3

2.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

454

3028

1.51

14.77

10.4

7.9

kpa

12.6

13.6

3.30

437

2886

(3011412) CD3 cells [#/volume] in Blood

409

2.40

14.73

3.0

2.5

e9/l

1.3

0.09

228

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

784

5794

1.38

14.67

3.7

2.9

ng/l

214.2

506.2

4.02

464

3487

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

323

2.58

14.55

1.3

1.5

—

(3003396) Base excess in Arterial blood by calculation

454

3044

1.51

14.40

10.4

7.8

mmol/l

1.1

0.7

1.11

355

2316

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

163

829

1.96

14.38

1.9

2.0

ug/l

1.6

2.1

0.28

141

736

(3044640) Blood type and Crossmatch panel - Blood

1503

12242

1.28

14.08

2.6

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1096

8568

1.31

14.07

2.5

2.2

umol/l

2459.9

3695.9

0.70

981

7726

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

310

1919

1.62

13.99

1.7

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1185

9372

1.30

13.96

3.7

3.0

kg/l

1.0

0.81

160

1285

(40768797) Stomach Pathology biopsy report

628

4509

1.41

13.91

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

471

3206

1.48

13.87

3.1

2.6

g/l

0.2

0.34

444

2983

(1616796) Gas panel - Central venous blood

141

693

2.03

13.72

4.2

3.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

278

2.64

13.46

1.4

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

234

2.80

13.41

3.3

2.3

18.5

11.2

2.14

226

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4048

36853

1.24

13.35

4.4

4.0

mmol/mol

37.9

37.6

1.10

3822

34896

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

534

3761

1.44

13.15

5.3

4.8

—

(3017181) Myelocytes/100 leukocytes in Blood

454

3101

1.48

13.14

4.5

4.3

0.6

0.9

2.24

110

737

(3047007) Chlamydophila sp Ab [Presence] in Serum

150

766

1.95

13.11

1.2

—

(3019060) Gas panel - Arterial blood

257

1545

1.66

13.04

4.8

4.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

438

2975

1.48

13.03

4.5

4.4

0.0

0.1

2.48

106

688

(3000060) B lymphocytes [#/volume] in Blood

185

3.00

12.93

3.5

2.2

e6/l

326.9

232.7

0.70

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

246

1468

1.68

12.84

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

753

1.94

12.75

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

4568

42244

1.25

12.51

15.8

11.6

13.4

13.3

0.90

4478

41287

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1375

1.69

12.44

1.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

420

2856

1.48

12.43

4.2

4.0

0.3

0.6

1.75

551

(3024980) IgG subclass 4 [Mass/volume] in Serum

138

698

1.97

12.43

1.5

1.7

g/l

0.7

0.8

1.24

103

532

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2254

19429

1.22

12.35

4.3

3.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

332

2.42

12.33

1.6

1.2

u/ml

0.7

0.4

0.61

101

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

167

903

1.84

12.29

1.7

—

(3022145) Colonoscopy Study observation

552

3960

1.41

12.25

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5309

50050

1.32

12.16

9.6

7.6

u/l

28.7

27.8

1.07

5173

48522

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

294

1860

1.58

12.15

3.6

2.8

ng/l

141.4

144.2

0.04

262

1623

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4439

40989

1.24

11.97

10.8

8.2

ml/min/173m2

95.6

95.4

0.16

3646

32274

(3043409) Potassium [Moles/volume] in Arterial blood

136

694

1.95

11.95

5.1

3.7

mmol/l

3.8

0.06

130

645

(3000494) Fungus identified in Specimen by Culture

617

4543

1.37

11.72

1.6

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

468

3286

1.43

11.72

3.9

4.3

u/l

232.9

240.5

0.55

445

3130

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

202

2.79

11.64

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

202

2.79

11.64

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

202

2.79

11.64

1.3

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

336

2.36

11.56

1.1

iu/ml

5.5

7.2

0.39

(3051611) Lipemic interference index of Serum or Plasma

303

2.42

11.32

3.6

3.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

210

1245

1.68

11.28

2.0

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

366

2470

1.49

11.26

11.0

8.7

g/l

124.9

124.5

0.12

354

2380

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.58

11.22

1.4

1.2

—

(3025159) Blasts/100 leukocytes in Blood

413

2856

1.45

11.22

4.7

4.4

0.0

0.3

0.91

592

(3009445) Proteinase 3 Ab [Units/volume] in Serum

238

1467

1.62

10.99

1.4

1.5

u/ml

5.4

8.9

1.07

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

332

2.33

10.96

3.3

2.5

e9/l

0.2

0.64

264

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

298

1938

1.54

10.93

2.4

1.9

ug/l

4.0

7.0

5.14

255

1697

(3011397) Hemoglobin [Presence] in Urine by Test strip

1159

9403

1.26

10.85

3.6

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4409

40833

1.22

10.79

3.5

3.2

mmol/l

5.7

5.6

0.90

4129

38096

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

341

2.30

10.76

3.3

2.5

e6/l

520.5

541.5

0.14

264

(3041096) Erythrocytes [Presence] in Urine by Automated

1489

12436

1.24

10.74

3.1

2.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

412

2875

1.44

10.67

3.3

pmol/l

4.7

0.07

358

2591

(3021960) Folate [Moles/volume] in Serum or Plasma

892

7034

1.29

10.49

1.5

1.4

nmol/l

19.9

20.2

0.22

788

6246

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

494

2.05

10.43

1.5

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

123

639

1.91

10.31

4.8

3.0

u/ml

694.7

503.9

0.22

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

229

1421

1.61

10.31

4.1

2.9

g/l

3.5

0.13

221

1352

(3020393) Adenovirus Ag [Presence] in Stool

3.63

10.12

1.8

1.3

—

(3021901) Oxygen saturation in Capillary blood

102

501

2.02

10.06

5.2

2.6

—

(3035941) MCH [Entitic mass]

5819

55863

1.45

10.05

18.9

13.5

29.9

0.94

5766

55142

(3024731) MCV [Entitic volume]

5819

55863

1.45

10.05

18.9

13.5

89.2

89.3

1.72

5766

55144

(3010813) Leukocytes [#/volume] in Blood

5823

55909

1.45

10.04

19.0

13.6

e9/l

6.8

6.7

3.77

5698

54254

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

576

4297

1.35

10.04

3.4

2.7

umol/l

6.0

6.9

1.36

496

3672

(3020891) Body temperature

168

969

1.73

10.02

7.0

4.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

365

2.20

9.99

1.5

1.3

—

(3051651) Icteric interference index of Serum or Plasma

208

2.62

9.97

3.4

3.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

846

1.78

9.97

5.8

5.1

iu/ml

842.2

637.2

0.17

(3017446) Testosterone [Moles/volume] in Serum or Plasma

543

4019

1.36

9.96

2.3

2.1

nmol/l

12.6

12.8

0.29

478

3626

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

328

2.27

9.94

1.5

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

317

2.28

9.84

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

5819

55882

1.44

9.83

19.0

13.6

e12/l

4.6

0.17

5700

54243

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

185

1104

1.67

9.74

2.0

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

1190

9796

1.24

9.68

5.1

3.6

93.6

0.03

1160

9548

(3008152) Bicarbonate [Moles/volume] in Arterial blood

242

1545

1.56

9.68

7.3

6.5

mmol/l

24.6

24.4

0.41

228

1430

(3012501) Base excess in Blood by calculation

133

725

1.82

9.63

3.8

mmol/l

2.2

2.1

0.25

451

(3007461) Platelets [#/volume] in Blood

5808

55778

1.43

9.59

19.1

13.6

e9/l

261.1

258.3

2.76

5694

54233

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

173

2.74

9.57

1.7

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

449

3250

1.39

9.46

4.2

2.8

1.7

0.15

404

2936

(3000963) Hemoglobin [Mass/volume] in Blood

5819

55916

1.43

9.44

19.1

13.6

g/l

137.7

138.0

0.92

5766

55195

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.21

9.41

4.7

3.9

—

(3044889) 12 lead EKG panel

2900

26030

1.18

9.35

3.1

2.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

250

1624

1.54

9.27

2.8

2.3

e6/l

0.2

0.23

240

1557

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

421

3026

1.40

9.25

2.3

au/ml

11.4

20.9

3.71

253

(3025941) Bacteria identified in Stool by Culture

389

2764

1.41

9.14

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

410

2947

1.40

9.01

1.2

titre

47.5

192.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

352

2.14

8.80

7.1

6.5

mg/l

10.1

10.2

0.12

328

(3023183) Ammonium ion [Moles/volume] in Plasma

126

698

1.79

8.70

3.5

2.7

umol/l

36.6

34.4

0.49

109

605

(3009508) Creatinine [Moles/volume] in Urine

1313

11031

1.22

8.69

3.5

3.2

mmol/l

8.5

8.6

0.39

1149

9676

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

217

1387

1.56

8.67

4.3

2.8

164.3

168.2

0.28

210

1319

(3010421) pH of Blood

146

845

1.72

8.66

3.7

7.4

0.15

130

713

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

107

3.14

8.63

1.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

107

3.14

8.63

1.0

1.4

—

(3000492) Spirometry study

614

4725

1.31

8.62

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

126

700

1.79

8.62

1.4

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

376

2.08

8.54

3.2

2.5

43.1

44.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3681

33833

1.18

8.54

3.3

2.7

u/l

39.2

38.0

0.43

3523

32371

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

545

4132

1.33

8.51

2.5

2.3

u/l

5531.1

6257.6

0.22

200

1602

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

410

2.03

8.49

1.5

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

485

1.94

8.47

2.7

3.1

mu/l

26.1

29.1

0.20

458

(3036489) Thrombin time

251

1668

1.50

8.40

3.6

2.4

21.2

21.3

0.19

218

1425

(3014007) Fractional oxyhemoglobin in Arterial blood

253

1685

1.50

8.38

15.1

10.1

94.2

94.3

0.10

253

1679

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

144

839

1.71

8.35

4.0

3.5

54.2

56.2

1.13

144

839

(3013005) Retinol [Moles/volume] in Serum or Plasma

247

2.32

8.24

3.1

2.3

umol/l

1.9

1.8

0.39

236

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1122

9334

1.22

8.13

2.6

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

318

2228

1.43

8.11

3.4

2.7

e9/l

70.9

0.00

234

1574

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

485

3642

1.34

8.09

2.7

2.4

u/l

42.1

38.1

0.23

427

3132

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

220

1436

1.53

8.03

2.3

2.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

206

1328

1.54

7.96

4.3

4.1

1.3

0.06

206

1320

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

347

2478

1.40

7.95

4.1

3.5

mmol/l

1.2

1.58

298

2150

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

311

2180

1.43

7.92

5.5

4.2

ng/l

79.1

77.9

0.06

277

1975

(40768804) Tissue Pathology biopsy report

1768

15382

1.18

7.88

1.9

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

135

2.78

7.84

1.0

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

125

714

1.74

7.81

6.6

4.1

u/ml

0.3

0.12

360

(40761536) Microorganisms panel - Urine sediment

499

3783

1.32

7.80

3.6

3.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

277

1907

1.45

7.78

2.0

2.4

g/l

66.6

67.3

0.74

255

1784

(3035637) Corticotropin [Mass/volume] in Plasma

102

551

1.84

7.69

1.7

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

138

2.72

7.54

1.0

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

234

1569

1.49

7.53

1.3

u/ml

0.4

0.8

0.79

115

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

169

1055

1.59

7.53

2.5

ug/l

203.7

655.6

1.16

157

964

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

232

1554

1.49

7.51

4.3

2.7

92.0

94.5

1.00

218

1443

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

436

3260

1.34

7.50

3.1

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

144

2.68

7.50

1.7

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

823

6696

1.24

7.32

1.5

1.6

pmol/l

46724094.9

31927096.4

0.23

702

5782

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

380

2795

1.36

7.29

1.2

1.3

au/ml

20.6

42.8

2.52

106

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

256

1762

1.45

7.22

1.2

1.1

u/ml

2.1

2.2

0.09

118

824

(3019309) Folate [Moles/volume] in Red Blood Cells

629

4970

1.27

7.20

1.7

nmol/l

1119.3

1158.3

0.54

469

3832

(40767503) Oxygen content in Capillary blood by calculation

111

631

1.74

7.10

2.6

2.3

16.9

17.3

0.47

307

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

147

906

1.61

6.94

1.1

au/ml

28.1

13.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

103

577

1.77

6.93

3.5

3.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

111

2.85

6.93

1.7

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

130

779

1.66

6.86

6.4

5.4

umol/l

380.2

380.6

0.01

117

691

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

222

1502

1.47

6.86

15.7

10.4

mmol/l

24.3

24.1

0.50

204

1426

(3000570) Elastase.pancreatic [Mass/mass] in Stool

141

866

1.62

6.76

1.4

ug/g

299.6

299.1

0.01

460

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

169

1087

1.55

6.66

1.7

1.5

u/ml

103.5

106.1

0.13

198

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

513

3994

1.29

6.61

1.3

1.2

iu/ml

144.4

153.3

0.12

200

1501

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

451

1.84

6.52

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

231

1597

1.44

6.41

2.1

2.0

u/l

40.9

39.9

0.29

218

1470

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

468

1.82

6.41

1.9

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

119

711

1.66

6.38

2.3

2.1

g/l

131.8

133.7

0.45

538

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

175

1147

1.52

6.35

1.7

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

339

2505

1.35

6.35

1.7

1.5

u/l

7.3

7.7

0.28

276

1987

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

194

1300

1.48

6.33

1.5

1.3

u/ml

222.8

228.2

0.10

121

784

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

174

1141

1.52

6.30

1.9

1.4

mg/l

456.9

469.9

0.12

165

1094

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

343

2547

1.34

6.22

2.8

2.3

ml/min/173m2

74.4

78.7

0.88

121

918

(3027273) Bicarbonate [Moles/volume] in Venous blood

184

1225

1.49

6.20

4.2

3.4

mmol/l

24.9

25.2

0.43

177

1178

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4609

43545

1.17

6.19

3.5

3.3

mmol/l

4.7

3.26

4385

41479

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

215

2.21

6.16

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

540

1.74

6.13

1.2

1.1

—

(3008898) HLA-B27 [Presence]

300

2192

1.36

6.05

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

228

1591

1.43

6.03

1.2

1.1

u/ml

5.2

7.7

1.51

139

969

(3044290) Cell count panel - Cerebral spinal fluid

148

949

1.55

5.96

2.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

110

2.69

5.91

1.8

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4574

43238

1.16

5.90

3.5

3.2

mmol/l

1.4

4.97

4341

41094

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

2.52

5.90

1.7

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

188

2.26

5.86

1.1

100.7

93.2

0.86

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

199

1362

1.45

5.86

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

191

1299

1.46

5.81

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

543

1.71

5.76

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

228

2.12

5.75

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

357

1.88

5.71

1.9

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.34

5.70

7.3

3.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

178

2.28

5.69

1.2

94.3

94.2

0.01

(3008401) Mugwort IgE Ab [Units/volume] in Serum

216

1510

1.42

5.68

1.2

1.1

u/ml

1.2

1.3

0.08

109

775

(3042631) Mycobacterium sp identified in Specimen

244

2.07

5.58

3.8

2.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4623

43810

1.15

5.48

3.7

3.5

mmol/l

2.8

2.9

1.03

4376

41430

(3045414) Leukocytes [Presence] in Urine

231

1647

1.40

5.45

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

227

2.09

5.42

1.2

u/ml

22.4

9.9

0.59

169

(3026389) Candida sp identified in Specimen by Organism specific culture

569

1.67

5.38

1.5

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.73

5.37

6.1

4.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.73

5.37

6.3

4.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

309

1.92

5.36

3.5

3.1

au/ml

151.3

139.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

961

8184

1.18

5.27

4.2

mg/mmol

8.2

12.0

0.89

632

5533

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

117

2.53

5.27

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.53

5.27

1.2

1.1

71.9

79.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

242

1750

1.38

5.25

4.0

4.2

g/l

132.2

132.9

0.16

235

1715

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

183

1261

1.44

5.24

1.8

pmol/l

187.6

204.0

1.25

173

1210

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.48

5.21

9.2

6.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

383

1.81

5.20

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

923

7844

1.19

5.19

3.5

3.4

mg/l

565.7

275.3

0.85

593

5204

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

118

2.51

5.18

1.2

1.1

71.8

88.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

384

1.80

5.16

1.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

539

1.67

5.13

1.8

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

385

1.80

5.12

1.3

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

152

1016

1.48

5.10

1.9

1.4

mmol/l

3.7

3.6

0.49

133

956

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

386

1.79

5.08

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4395

41582

1.14

5.04

3.2

3.0

mmol/l

1.3

1.20

4180

39498

(3003740) Influenza virus B Ag [Presence] in Specimen

170

1165

1.45

5.03

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

431

1.74

5.02

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

170

1166

1.45

5.01

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

235

2.02

4.98

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

152

1022

1.48

4.96

2.3

1.6

e6/l

176.9

4617.5

0.65

124

814

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

152

1023

1.47

4.94

2.2

1.5

e6/l

23.9

27.7

0.09

118

774

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

397

1.77

4.93

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

509

1.67

4.88

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

148

998

1.47

4.78

1.2

1.3

u/ml

1.8

7.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.43

4.76

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

150

1015

1.47

4.76

1.2

1.3

u/ml

3.4

13.0

2.57

150

(3017732) Neutrophils [#/volume] in Blood

368

2869

1.28

4.75

2.6

2.4

e9/l

4.0

4.2

0.40

298

2404

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1431

12659

1.15

4.75

2.3

2.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

339

1.81

4.66

4.6

3.7

mg/l

7.2

8.5

1.24

273

(3024522) Salmonella sp identified in Specimen by Organism specific culture

390

1.75

4.64

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

188

2.10

4.64

1.2

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

442

1.70

4.62

3.8

2.9

0.7

1.3

1.71

354

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

215

2.02

4.61

1.1

nmol/l

5.7

5.1

0.04

(3019225) pH of Specimen

362

2831

1.27

4.57

3.6

3.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

211

1530

1.37

4.55

14.0

10.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

212

1539

1.37

4.54

1.2

1.1

u/ml

3.0

0.00

432

(3008757) Leukocyte morphology finding [Identifier] in Blood

342

1.79

4.54

3.9

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

343

2668

1.28

4.53

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.60

4.49

10.0

6.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

161

1118

1.43

4.48

1.2

1.3

u/ml

19.2

32.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

345

1.78

4.42

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

212

2.00

4.41

2.3

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

570

1.60

4.40

1.5

1.9

g/l

0.0

0.00

534

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

645

5388

1.20

4.40

2.3

2.6

mmol/l

2.4

0.01

569

4692

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

160

2.16

4.37

2.5

2.3

umol/l

15.7

17.2

0.29

160

(3017143) Hepatitis C virus Ab [Presence] in Serum

998

8658

1.16

4.32

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

739

1.51

4.27

1.5

1.9

g/l

10.2

10.5

0.35

645

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

387

1.71

4.21

1.1

1.3

titre

216.4

269.9

0.18

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.69

4.21

1.5

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.55

4.16

1.5

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

217

1.96

4.16

4.8

3.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

211

1.97

4.11

1.3

1.6

nmol/l

1.9

3.4

0.69

173

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

627

1.55

4.11

1.5

1.8

g/l

39.7

38.5

1.36

552

(3023511) Choriogonadotropin [Units/volume] in Urine

275

2107

1.30

4.11

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

120

2.30

4.09

1.7

2.1

mmol/l

9.5

10.2

0.42

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

628

1.54

4.09

1.6

1.8

g/l

0.0

0.65

590

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.58

4.09

1.7

2.7

mg/l

9.7

32.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

132

900

1.45

4.08

1.2

u/ml

50.4

51.8

0.03

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1547

13879

1.13

4.06

2.4

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.86

4.04

1.4

nmol/l

18.3

16.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

410

3306

1.24

4.01

1.5

1.4

iu/l

15.5

19.0

2.04

334

2725

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

334

1.75

4.00

1.1

1.3

mmol/l

2.0

1.8

0.54

314

(44813793)

401

1.68

3.99

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

800

1.47

3.97

1.6

1.9

g/l

4.1

3.8

1.22

581

(36660697) Celiac disease serology panel - Serum

567

4727

1.20

3.97

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

801

1.47

3.95

1.6

1.9

g/l

7.1

7.3

0.50

618

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

801

1.47

3.95

1.6

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

167

1196

1.38

3.94

1.8

2.0

g/l

1.5

1.3

1.38

146

1041

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.46

3.94

1.1

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

486

1.61

3.93

1.3

1.5

promille

1.6

1.3

0.79

387

(1002224) Polysomnography panel

291

2260

1.28

3.93

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

564

1.56

3.91

1.6

1.9

g/l

0.0

0.00

533

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

224

1681

1.32

3.91

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

497

1.59

3.84

1.3

umol/l

5.4

6.1

0.88

462

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.44

3.82

1.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.16

3.81

3.4

2.2

umol/l

42.6

57.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.84

3.78

1.2

1.1

u/ml

4.1

2.3

0.27

(3011841) English Walnut IgE Ab [Units/volume] in Serum

131

2.18

3.77

1.1

u/ml

15.2

9.6

0.15

108

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

401

1.65

3.74

1.5

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

233

1.86

3.73

2.2

2.8

umol/l

103.8

172.0

1.05

118

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

119

2.24

3.72

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

119

2.24

3.72

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

119

2.24

3.72

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

119

2.24

3.72

1.3

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

394

1.66

3.72

2.6

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

103

683

1.49

3.70

2.1

2.0

g/l

0.6

0.06

614

(3011288) Drugs identified in Urine by Screen method

426

3481

1.22

3.69

3.6

2.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

166

2.02

3.64

1.2

1.5

pmol/l

13.4

13.8

0.26

141

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

935

8172

1.15

3.64

1.8

1.4

0.45

831

7457

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

760

1.46

3.60

1.6

1.9

g/l

3.0

3.1

1.01

607

(3014133) Dog dander IgE Ab [Units/volume] in Serum

172

1260

1.35

3.56

1.1

u/ml

6.0

5.1

0.23

560

(3045424) Erythrocytes [Presence] in Urine

609

1.51

3.56

1.3

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

222

1688

1.31

3.56

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

159

1151

1.37

3.55

1.9

2.0

iu/l

3.1

4.4

2.29

451

(3047181) Lactate [Moles/volume] in Blood

135

952

1.40

3.53

4.1

5.6

mmol/l

1.3

1.2

0.13

113

820

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

2.05

3.47

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

402

1.62

3.46

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

5053

48571

1.13

3.46

14.0

10.1

40.8

0.30

4186

40544

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

460

3818

1.20

3.41

3.5

3.3

31.2

31.6

0.39

345

2832

(3013139) Helicobacter pylori Ag [Presence] in Stool

337

2712

1.24

3.40

1.2

—

(4015189)

3.13

3.39

3.1

2.6

—

(4034850)

155

1128

1.36

3.37

8.6

6.9

—

(3028707) Methadone [Presence] in Urine by Screen method

265

2079

1.27

3.35

3.5

2.9

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

138

2.07

3.34

1.0

1.1

u/ml

8.1

4.2

0.42

110

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

316

1.69

3.32

3.8

2.6

e6/l

785.1

836.9

0.13

115

(3011897) Casein IgE Ab [Units/volume] in Serum

193

1.89

3.32

1.5

1.4

u/ml

47.3

2.2

1.36

(3023430) Cat dander IgE Ab [Units/volume] in Serum

157

1150

1.35

3.28

1.1

u/ml

5.2

7.1

0.73

527

(3006653) Thiamine [Moles/volume] in Blood

173

1.94

3.28

1.4

1.3

nmol/l

135.1

136.0

0.04

173

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.79

3.25

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

423

3501

1.20

3.24

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

345

2799

1.23

3.24

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

172

1281

1.33

3.23

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

202

1.86

3.22

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

190

1436

1.31

3.22

2.1

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

327

1.66

3.20

1.4

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1070

9517

1.13

3.18

1.6

mmol/l

1.5

1.4

0.85

931

8378

(3005011) Chlamydia sp Ab [Titer] in Serum

2.43

3.18

1.2

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

171

1277

1.33

3.16

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

6.27

3.14

7.9

1.9

mmol/l

4.2

4.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

329

1.65

3.13

1.4

1.1

—

(3022621) pH of Urine by Test strip

291

2330

1.24

3.10

2.7

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

300

1.68

3.10

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

205

1.83

3.09

1.7

2.3

ng/l

133.4

113.9

0.68

165

(3023410) Appearance of Cerebral spinal fluid

518

1.51

3.06

3.2

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

246

1936

1.26

3.06

1.8

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.59

3.03

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.37

3.02

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

172

1295

1.32

3.02

1.2

1.4

titre

61.7

79.9

0.85

129

(3041672) Baker's yeast Ab [Presence] in Serum

2.76

2.99

1.1

—

(40768443) Skin Pathology biopsy report

194

1487

1.29

2.99

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

442

1.54

2.98

1.2

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.19

2.97

22.1

3.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

171

1291

1.31

2.95

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

180

1.86

2.95

1.4

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.46

2.94

2.2

13.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

133

969

1.36

2.92

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

548

1.48

2.92

1.2

1.1

u/ml

25.0

7.3

0.47

188

(3045683) HLA typing for celiac disease panel - Blood or Tissue

390

1.57

2.91

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

557

1.47

2.89

1.3

1.1

u/ml

18.1

1.9

1.31

223

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.31

2.87

1.5

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.31

2.87

1.5

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

323

1.62

2.84

1.3

—

(3016135) IgD [Mass/volume] in Serum

6.57

2.83

1.3

1.0

mg/l

32.2

65.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

114

2.08

2.82

1.8

2.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

127

927

1.36

2.78

1.5

1.4

u/l

13.2

18.0

1.59

114

798

(3012494) Peanut IgE Ab [Units/volume] in Serum

288

1.65

2.74

1.2

1.1

u/ml

19.0

6.7

0.43

195

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

237

1.71

2.69

2.8

2.7

39.1

43.6

0.85

(40757373) Influenza virus identified in Isolate

2.51

2.69

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

698

1.40

2.68

1.9

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1007

9016

1.12

2.67

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1456

13294

1.10

2.66

1.8

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

129

951

1.34

2.66

1.1

u/ml

2.5

3.5

0.70

497

(3032641) Amino acids panel - Urine

4.15

2.63

1.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.67

2.63

1.5

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

131

1.96

2.63

1.7

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.46

2.61

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

132

1.94

2.58

2.1

mmol/l

0.9

1.9

1.81

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

434

1.50

2.58

1.1

—

(3000330) Specific gravity of Urine by Test strip

194

1521

1.26

2.55

2.7

2.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

119

1.99

2.54

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

1.99

2.54

1.6

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

119

1.99

2.54

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

119

1.99

2.54

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

133

993

1.33

2.53

1.1

u/ml

0.1

0.5

2.12

250

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

1.86

2.53

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

140

1.90

2.53

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

476

4073

1.16

2.52

2.7

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

477

1.47

2.51

1.3

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.56

2.45

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

298

1.59

2.43

1.1

u/l

61.5

86.2

1.31

203

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

143

1086

1.30

2.43

4.1

5.1

1.8

1.7

0.33

133

1009

(21494755) Public health laboratory ask at order entry panel

720

7877

0.89

2.42

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1686

15567

1.09

2.40

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.51

2.36

3.8

2.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.10

2.35

1.1

—

(40768446) Kidney Pathology biopsy report

180

1.75

2.35

2.2

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

795

7082

1.12

2.32

3.4

3.3

ug/l

1.5

1.8

1.58

714

6455

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

736

6528

1.12

2.31

2.1

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

527

1.42

2.31

2.5

1.6

—

(3002256) Pathology report gross observation

523

4540

1.15

2.30

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

625

5495

1.13

2.27

1.9

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.11

2.25

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

111

1.95

2.25

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.81

2.23

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

623

1.38

2.21

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

169

1.75

2.20

1.7

nmol/l

0.1

0.2

1.11

122

(3007930) Methemoglobin/Hemoglobin.total in Blood

140

1077

1.29

2.19

3.9

5.2

0.9

1.30

129

1000

(3014051) Protein [Presence] in Urine by Test strip

110

819

1.33

2.18

2.1

1.9

—

(3042733) HLA Ab [Presence] in Serum

155

1.78

2.18

4.4

4.6

—

(3013466) aPTT in Blood by Coagulation assay

3.06

2.18

1.2

1.1

36.5

37.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

120

905

1.31

2.18

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

600

1.38

2.17

2.0

1.4

—

(3011985) Renin [Units/volume] in Plasma

476

1.43

2.17

1.7

1.6

mu/l

96.5

70.7

0.38

423

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

1.95

2.16

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.30

2.14

1.0

u/ml

1.7

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.74

2.13

7.2

5.5

mmol/l

4.7

6.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.22

2.12

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

465

4031

1.15

2.11

2.3

2.2

ug/l

0.7

0.21

208

2012

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.96

2.10

1.2

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

620

5478

1.13

2.09

3.1

2.9

20.8

21.3

0.22

189

1753

(3006922) Hepatitis E virus Ab [Presence] in Serum

366

1.48

2.09

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

136

1.81

2.07

1.1

u/l

28.9

15.6

0.35

107

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.99

2.07

1.1

—

(3017569) Oxygen content in Arterial blood

101

1.95

2.06

1.2

2.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

101

1.95

2.06

1.1

u/ml

0.2

0.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.92

2.04

1.2

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

137

1.80

2.03

1.1

u/l

87.7

74.6

0.20

117

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

385

1.46

2.02

1.5

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

266

1.56

2.01

3.4

2.5

51.3

55.6

0.58

174

(3034274) Bile acid [Moles/volume] in Serum --fasting

153

1205

1.26

2.01

2.6

2.4

umol/l

6.8

6.1

0.30

107

914

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

243

1.58

2.00

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1861

17365

1.08

2.00

2.2

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

131

1013

1.28

2.00

2.3

2.1

mg/l

10.5

10.6

0.06

126

965

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

338

1.49

1.99

2.0

1.9

mg/l

38.5

27.7

0.44

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

518

1.39

1.99

1.2

1.1

mg/l

29.7

39.6

2.62

428

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

205

1.64

1.99

1.8

mg/l

3.5

3.2

0.18

197

(4198724)

535

1.38

1.98

3.3

2.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

183

1473

1.23

1.98

1.7

1.8

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.99

1.97

2.7

3.5

4.5

6.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

1.83

1.97

3.7

—

(3006598) pH of Arterial cord blood

132

1.79

1.94

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

118

1.84

1.92

1.1

u/ml

19.5

2.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

118

1.84

1.92

1.0

1.1

u/ml

0.9

0.01

(3016879) Cocaine [Presence] in Urine

552

4878

1.12

1.88

2.4

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

438

0.60

1.88

3.3

3.4

u/ml

111.1

27.3

0.62

420

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

458

1.40

1.87

1.3

1.5

pmol/l

304.0

335.0

0.40

362

(3021387) Prolactin [Units/volume] in Serum or Plasma

375

3236

1.15

1.85

1.6

mu/l

318.1

319.9

0.03

327

2914

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

204

1675

1.21

1.84

1.1

u/ml

4.5

4.8

0.05

258

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

202

1658

1.21

1.83

1.6

1.7

iu/ml

0.2

0.1

0.16

309

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

273

1.52

1.82

1.4

1.6

37.7

0.00

174

(3000764) Benzodiazepines [Presence] in Urine

591

5256

1.12

1.81

2.4

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

234

1.56

1.81

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

403

1.42

1.81

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

160

1284

1.23

1.81

1.4

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

150

1.71

1.81

1.5

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

150

1.71

1.81

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

173

1.65

1.79

1.6

1.5

u/l

4.1

6.3

0.28

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.00

1.77

1.1

u/ml

8.3

11.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

405

1.41

1.77

3.9

3.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

228

1.56

1.76

1.3

1.5

u/l

5.1

6.4

0.96

196

(3034891) Synovial lining cells/100 cells in Synovial fluid

144

1.71

1.75

1.2

1.4

5.4

5.6

—

(3021788) Differential panel - Synovial fluid

557

1.35

1.74

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

746

1.30

1.73

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

409

3569

1.14

1.73

1.3

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

237

1.54

1.73

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.28

1.71

1.3

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

450

1.38

1.70

1.2

u/l

92.7

27.8

0.69

388

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.87

1.69

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

280

1.48

1.64

1.8

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.03

1.63

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

118

1.75

1.62

1.1

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

104

807

1.27

1.61

1.1

—

(3027008) Opiates [Presence] in Urine

592

5306

1.11

1.60

2.4

2.0

—

(3028300) Cannabinoids [Presence] in Urine

593

5316

1.11

1.60

2.5

2.1

—

(4146454)

242

1.51

1.59

2.5

2.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.52

1.59

1.2

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

619

5563

1.11

1.59

1.4

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.21

1.57

5.5

2.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.46

1.56

1.8

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

534

1.33

1.56

1.1

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

543

1.33

1.55

3.4

3.0

mg/l

34.1

33.5

0.03

432

(3052592) Norovirus Ag [Presence] in Stool

2.29

1.54

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

156

1273

1.21

1.54

4.0

3.6

g/l

0.5

0.4

0.14

625

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

350

1.41

1.54

1.5

1.6

54.1

54.4

0.02

223

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

143

1.65

1.52

1.0

1.3

33.4

12.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

152

1242

1.21

1.50

1.5

1.6

nmol/l

0.3

0.5

1.25

123

1048

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

158

1296

1.21

1.49

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

694

1.28

1.48

1.5

1.7

e6/l

5879.0

14217.9

3.48

510

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

255

1.47

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

455

1.34

1.46

3.9

4.8

u/ml

14.8

105.5

3.35

149

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

879

8065

1.08

1.45

2.3

2.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

338

1.40

1.45

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

153

1.61

1.44

7.4

2.5

umol/l

89.6

76.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.83

1.43

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

373

1.38

1.41

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

225

1.49

1.41

2.7

2.6

mg/l

9.4

9.7

0.11

183

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

209

1.51

1.41

2.1

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

621

1.29

1.41

1.5

1.4

—

(3007463) Buprenorphine [Presence] in Urine

2.19

1.41

8.4

5.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

315

1.41

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

407

1.36

1.41

1.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

340

1.39

1.41

1.0

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

544

1.31

1.40

3.4

3.0

mg/l

42.7

63.6

0.76

432

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

291

1.42

1.39

1.4

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.08

1.39

3.4

1.5

—

(3024928) Oxygen saturation in Venous blood

754

1.26

1.38

3.3

5.2

—

(3035933) Granulocytes/100 leukocytes in Blood

244

1.45

1.34

1.7

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

224

1914

1.16

1.34

2.5

2.6

u/ml

30.6

42.7

1.08

213

1858

(3027944) Amphetamines [Presence] in Urine

578

5227

1.10

1.34

2.4

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.57

1.34

1.5

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

1.72

1.34

1.2

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

1.72

1.34

1.2

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

146

0.47

1.31

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

215

2432

0.87

1.30

1.6

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

287

1.41

1.30

3.2

nmol/l

0.8

0.29

223

(21494434) Karyotype in Bone marrow

214

1.47

1.29

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

221

2490

0.87

1.28

1.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

116

941

1.22

1.27

1.1

—

(3044941) Cell count panel - Synovial fluid

501

1.30

1.27

1.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

484

1.30

1.26

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

215

2424

0.87

1.26

1.6

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

365

1.35

1.25

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

332

1.37

1.24

1.1

1.2

ratio

1.1

0.05

130

(3042517) Benzodiazepines panel - Urine

121

1.63

1.23

4.5

2.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

400

1.33

1.23

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1.35

1.23

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1.35

1.23

1.1

—

(3015183) Erythrocyte sedimentation rate

324

1.37

1.23

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.05

1.23

7.7

3.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.23

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

106

1.67

1.22

1.2

1.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.73

1.22

1.2

—

(3045142) Bone marrow Pathology biopsy report

308

1.38

1.21

1.7

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.76

1.21

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

505

1.29

1.21

1.1

mg/l

198.0

240.0

1.84

443

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1.34

1.20

1.1

—

(3014271) Vancomycin [Susceptibility]

1.71

1.19

2.6

2.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

629

1.26

1.18

3.5

5.4

62.4

65.8

0.77

624

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

243

1.42

1.18

1.2

u/ml

19.2

59.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.83

1.18

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

369

1.34

1.18

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

369

1.34

1.18

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

268

1.40

1.18

2.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

507

1.28

1.18

1.1

1.0

u/ml

0.5

1.5

0.76

104

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

674

1.24

1.17

2.6

2.5

ug/min

150.6

125.2

0.16

436

(3051387) C reactive protein [Mass/volume] in Capillary blood

103

834

1.22

1.17

2.9

2.7

mg/l

24.0

26.8

0.31

520

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

104

843

1.22

1.17

1.8

2.6

nmol/l

0.8

0.7

0.96

723

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

763

1.23

1.17

1.4

1.5

mmol/l

6.4

6.7

0.56

528

(3000034) Microalbumin [Mass/volume] in Urine

244

1.41

1.16

3.0

3.1

mg/l

65.3

80.6

0.18

176

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

187

1.48

1.15

2.2

1.6

u/field

0.6

4.8

2.77

132

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

212

1.44

1.14

1.1

u/ml

3.8

14.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

237

1.41

1.13

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

317

2809

1.12

1.13

1.4

1.3

miu/ml

248.3

222.1

0.63

149

1366

(3050129) First trimester maternal screen panel - Serum or Plasma

364

3943

0.90

1.13

1.5

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.97

1.09

13.3

3.3

umol/l

31.0

44.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

110

1.61

1.09

1.1

1.0

u/ml

0.4

0.2

—

(3016750) Collection duration of Urine

182

1.46

1.08

2.0

2.3

min

527.4

507.7

0.38

143

(3042111) Morphology [Interpretation] in Bone marrow Narrative

403

1.30

1.05

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

649

1.23

1.04

2.7

3.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

250

1.38

1.04

1.0

1.1

97.9

90.0

0.80

203

(40761995) Spermatozoa Progressive [#/volume] in Semen

455

0.73

1.02

3.6

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

455

0.73

1.02

7.2

6.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.03

1.01

1.0

1.1

umol/24h

1.7

1.5

—

(3024471) HLA-A [Type]

161

1.47

0.99

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.64

0.98

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.64

0.98

17.5

5.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

530

1.25

0.98

2.9

ratio

1.9

1.7

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.97

0.98

1.0

—

(3024932) HLA-DR beta [Type]

162

1.46

0.97

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

222

1949

1.13

0.96

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

122

1.53

0.96

1.0

1.1

—

176.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

409

1.28

0.96

1.1

mg/l

274.4

277.1

0.11

372

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

560

1.23

0.94

1.4

1.3

pmol/l

88.1

131.0

0.26

134

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.78

0.94

1.9

2.7

—

(3039000) Anion gap in Blood

614

1.22

0.93

5.5

7.2

mmol/l

11.0

11.3

0.42

548

(3018572) Chloride [Moles/volume] in Blood

615

1.22

0.92

5.5

7.2

mmol/l

104.6

105.3

0.57

549

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.11

0.90

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

1.43

0.90

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.62

0.89

18.3

5.4

—

(4027681)

432

1.26

0.88

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

196

1720

1.13

0.88

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

450

1.25

0.87

2.8

1.7

mmol/l

70.4

69.1

0.07

366

(3040151) Glucose [Moles/volume] in Capillary blood

380

1.27

0.87

2.5

5.5

mmol/l

8.1

6.9

0.73

304

(3011648) Oxygen content in Venous blood

328

1.29

0.87

3.5

7.6

10.7

11.5

0.66

328

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.97

0.85

1.5

2.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.62

0.83

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

768

1.18

0.83

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.91

0.83

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.91

0.83

1.3

1.5

—

(3003338) MCHC [Mass/volume]

4674

45497

1.05

0.81

16.4

11.5

g/l

334.4

334.2

0.37

4646

45071

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

278

2990

0.91

0.81

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

276

2968

0.91

0.80

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

277

2977

0.91

0.80

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

278

2986

0.91

0.79

1.5

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.79

0.0

1.1

—

22.2

—

(3025130) Human papilloma virus identified in Specimen

764

1.17

0.78

1.8

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

299

3198

0.92

0.78

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

273

1.30

0.78

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.79

0.77

3.3

2.2

u/field

0.7

0.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

1.48

0.77

3.1

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

868

1.16

0.75

1.2

1.1

—

(3049233) Organic acids panel - Urine

2.05

0.74

1.2

1.1

—

(4094501)

742

1.17

0.73

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

109

0.54

0.71

10.5

8.3

—

(3004775) Volume in Urine collected for unspecified duration

225

1.31

0.71

2.0

2.3

803.0

624.8

1.07

164

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.72

0.70

1.0

1.8

ng/l

61.1

104.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.72

0.70

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.55

0.69

1.6

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

420

1.22

0.69

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.68

0.69

1.0

—

(4038314)

125

1.42

0.67

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.64

0.67

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.55

0.67

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

237

1.29

0.65

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

870

0.86

0.65

2.9

3.8

u/ml

1316.5

1704.4

0.09

749

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

289

0.75

0.65

1.5

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.76

0.65

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

299

1.25

0.65

1.4

1.2

—

(3035880) pH of Pleural fluid

1.51

0.64

1.0

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.57

0.64

2.2

1.1

—

(4281824)

308

0.77

0.61

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.61

0.61

1.6

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

287

2628

1.08

0.60

1.7

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

5.6

—

0.2

—

(3036603) Volume of Urine

224

1.28

0.58

1.4

1.6

2356.3

2328.6

—

(4306422)

805

1.14

0.58

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

621

1.16

0.58

1.1

g/l

1.4

1.5

1.61

560

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

233

1.27

0.58

6.6

8.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

421

4382

0.94

0.58

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

225

1.27

0.57

3.8

1.8

u/field

1.0

1.7

1.05

103

(3041806) Other cells [#/volume] in Blood by Manual count

660

1.15

0.56

1.6

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.42

0.55

1.1

1.3

nmol/l

147.6

137.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.50

0.54

1.2

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

245

1.25

0.53

2.2

ug/l

46.6

21.8

0.40

239

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.46

0.53

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

784

1.13

0.53

1.1

112.5

115.6

0.49

716

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

544

1.16

0.53

2.2

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

184

1.28

0.52

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.43

0.52

1.3

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

605

6211

0.95

0.51

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

168

1.29

0.50

1.2

1.1

—

(4035726)

279

2577

1.07

0.50

1.5

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.49

0.49

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

252

2321

1.07

0.49

1.7

1.6

mg/l

3.7

3.5

0.15

176

1495

(4211845)

195

1.26

0.49

2.6

2.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

220

0.76

0.49

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.50

0.47

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

440

1.16

0.47

1.5

3.9

u/ml

76.0

1017.2

0.95

404

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.27

0.46

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

267

2474

1.06

0.45

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.45

1.7

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

843

1.11

0.44

1.4

1.3

u/ml

4.1

4.2

0.01

299

(40768806) Pleura Pathology biopsy report

172

0.74

0.44

1.4

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

253

1.21

0.42

1.2

1.4

e6/l

26339.1

82536.1

0.87

177

(3019832) Treponema pallidum Ab [Presence] in Serum

1166

11193

1.03

0.42

1.8

—

(4268621)

586

0.87

0.42

2.5

2.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

1.24

0.41

1.6

2.2

nmol/l

1.6

1.3

0.55

158

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.41

0.0

1.0

—

(40758358) Immune stain study

0.00

0.40

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.39

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.39

0.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.39

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.39

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

266

0.81

0.39

1.1

1.2

—

(40768793) Breast Pathology biopsy report

757

0.90

0.38

1.3

—

(40768800) Prostate Pathology biopsy report

257

1.19

0.37

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

321

1.17

0.37

2.0

2.7

nmol/l

2.5

3.4

0.67

310

(1761868) Lipid panel - Serum or Plasma

1872

18121

1.02

0.37

2.2

2.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.37

0.37

2.4

1.5

umol/24h

363.2

321.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

177

1.22

0.36

1.3

1.5

e6/l

69295.0

96943.8

0.23

100

(3032868) Hemoglobin electrophoresis panel in Blood

0.63

0.35

1.2

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

115

1.28

0.35

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.37

0.34

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.37

0.34

1.1

1.0

—

(3022670) pH of Venous cord blood

1.34

0.34

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

102

925

1.09

0.34

1.6

1.5

pmol/l

63.7

121.1

1.85

902

(3020491) Glucose [Moles/volume] in Blood

324

0.85

0.33

1.2

1.5

mmol/l

6.8

5.8

0.86

242

(3048879) Bone marrow aspiration report

1.31

0.33

1.7

2.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

170

1.22

0.33

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

289

1.16

0.32

2.2

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

573

5813

0.97

0.32

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

701

1.10

0.32

1.5

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

328

1.14

0.30

1.0

1.1

u/l

1.0

1.25

153

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

331

0.86

0.30

1.1

miu/ml

1096.3

1519.3

1.50

331

(3017509) Phencyclidine [Presence] in Urine

118

1.25

0.30

1.5

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

114

1048

1.07

0.29

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

839

1.08

0.28

1.2

1.1

iu/ml

123.2

2206.5

0.92

223

(3008295) Osmolality of Serum or Plasma

386

1.12

0.28

1.4

1.8

mosm/kgh2o

286.5

287.2

0.07

297

(3014148) Varicella zoster virus Ab [Titer] in Serum

109

1001

1.07

0.28

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

119

1.24

0.28

1.3

—

(40768441) Liver Pathology biopsy report

303

1.14

0.27

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

156

1.20

0.27

1.7

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

1.22

0.27

1.3

1.7

—

601.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

530

1.10

0.26

1.4

mmol/l

10.2

11.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

361

1.12

0.26

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

760

1.08

0.24

3.0

2.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.18

0.24

1.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.18

0.24

1.0

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.18

0.24

1.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.18

0.24

1.0

1.2

—

(3000012) Reticulocyte production index

149

1.19

0.24

1.4

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.22

0.23

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

249

0.87

0.22

1.3

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.23

0.22

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.23

0.22

1.0

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.7

—

1.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.2

—

(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

0.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

124

1.19

0.21

2.1

2.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3004451) EKG impression Narrative

106

1.21

0.20

1.2

—

(3022689) Creatine [Moles/volume] in Urine

106

1.21

0.20

1.9

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

230.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

109

0.81

0.20

1.4

1.6

—

(3034426) Prothrombin time (PT)

181

1.14

0.19

1.6

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

238

1.12

0.18

1.1

1.0

—

(44806071)

1.17

0.17

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.20

0.17

1.7

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

660

1.06

0.16

1.5

2.2

—

(3020650) Glucose [Presence] in Urine

138

0.86

0.15

1.2

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

234

2241

1.03

0.15

3.0

4.1

ug/l

10.3

34.4

0.84

171

1686

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.15

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.20

0.15

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

110

1.16

0.14

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.80

0.14

1.0

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

300

0.92

0.13

1.4

1.5

mmol/l

4.9

5.3

1.69

289

(21494890) Protein electrophoresis panel - 24 hour Urine

197

1.10

0.12

1.6

1.9

—

(40765096) Chromosome analysis panel by Banding

1.17

0.12

1.4

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

1.13

0.12

1.6

1.4

ug/l

8.2

8.9

0.25

131

(3006462) Nitrate [Presence] in Urine

179

1.10

0.11

2.7

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

266

0.92

0.10

1.9

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

113

1.13

0.10

1.1

1.0

—

(3024263) Appearance of Synovial fluid

151

1.11

0.10

1.4

2.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

113

0.87

0.10

3.1

2.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.12

0.10

1.2

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

1.12

0.09

1.1

1.0

—

(44806420)

1.03

0.09

1.8

2.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.14

0.09

7.3

4.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

744

0.97

0.09

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

153

1538

0.98

0.08

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

122

1230

0.98

0.08

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.03

0.07

5.4

3.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.04

0.07

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.02

0.07

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

352

3504

0.99

0.07

1.5

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.04

0.07

4.6

5.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

120

0.90

0.07

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

0.90

0.07

1.5

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.86

0.06

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

1.10

0.06

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

180

0.93

0.06

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

1.09

0.06

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

459

0.96

0.06

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

149

0.92

0.05

1.2

—

(4024509)

279

0.95

0.05

1.6

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

1.08

0.05

1.1

—

(40768795) Lymph node Pathology biopsy report

351

1.04

0.05

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

120

1.07

0.02

3.7

3.4

—

(4133840)

159

1.05

0.02

1.1

—

(3017704) Immunofixation for Urine

101

1.07

0.02

1.3

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

151

1476

1.01

0.01

1.3

ug/l

3.8

4.4

0.38

142

1399

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

233

2284

1.00

0.01

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

296

1.00

0.00

4.6

3.1

—

(3045788) Cell count panel - Pleural fluid

163

1.03

0.00

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

0.98

0.00

4.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

0.98

0.00

4.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

285

2800

1.00

0.00

1.6

—

(40758292) HTLV I+II Ab panel - Serum

102

0.96

0.00

1.0

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

820

1.00

0.00

1.6

mmol/l

7.1

7.4

0.43

458

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

631

1.00

0.00

1.1

—

2.6

—

(3001556) Androgen free Index in Serum or Plasma

119

0.99

0.00

2.3

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

139

0.99

0.00

1.3

u/l

433.1

382.3

0.19

133

(3012441) Differential panel - Pleural fluid

178

1.00

0.00

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

812

0.99

0.00

1.4

1.3

u/ml

6.1

4.2

0.56

365

(3044009) aPTT.lupus sensitive (LA screen)

0.88

0.00

1.0

1.2

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

3.2

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.95

0.00

1.0

1.4

39.4

30.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.8

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.96

0.00

2.0

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

0.98

0.00

1.1

1.5

mu/l

277.4

62.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.00

0.00

8.0

4.4

mg/l

25.2

22.9

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

10.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_LARYNGITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_LARYNGITIS	1.413 [1.2, 1.67]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.13

During the follow-up period (1.1.1998 — 31.12.2019), 969 out of 30916 females with J10_LARYNGITIS died.

Males

Parameter	HR [95% CI]	p-value
J10_LARYNGITIS	1.41 [1.07, 1.87]	0.016
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 775 out of 49448 males with J10_LARYNGITIS died.

Mortality risk

Mortality risk for people of age

years, who have J10_LARYNGITIS.

N-year risk	Females	Males
1	0.139%	0.318%
5	0.796%	1.811%
10	1.901%	4.347%
15	3.684%	8.009%
20	6.57%	13.725%

Relationships between endpoints

↥

Index endpoint: J10_LARYNGITIS – Acute laryngitis and tracheitis

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acute laryngitis and tracheitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints